<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults - Pugh, R - 2015 | Cochrane Library</title> <meta content="Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults - Pugh, R - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007577.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults - Pugh, R - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007577.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007577.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults" name="citation_title"/> <meta content="Richard Pugh" name="citation_author"/> <meta content="Glan Clwyd Hospital" name="citation_author_institution"/> <meta content="pughr@hotmail.com" name="citation_author_email"/> <meta content="Chris Grant" name="citation_author"/> <meta content="University Hospital Aintree" name="citation_author_institution"/> <meta content="Richard PD Cooke" name="citation_author"/> <meta content="Alder Hey Children's NHS Foundation Trust" name="citation_author_institution"/> <meta content="Ged Dempsey" name="citation_author"/> <meta content="University Hospital Aintree" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD007577.pub3" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/08/24" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007577.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007577.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007577.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Critical Illness; Anti‐Bacterial Agents [*administration &amp; dosage]; Cross Infection [*drug therapy]; Drug Administration Schedule; Intensive Care Units; Pneumonia [*drug therapy, microbiology]; Pneumonia, Ventilator‐Associated [drug therapy, microbiology]; Randomized Controlled Trials as Topic; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007577.pub3&amp;doi=10.1002/14651858.CD007577.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="WcPhDegp";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007577\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007577\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","de","zh_HANT","ru","ms","ja","pl","fr","th","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007577.pub3",title:"Short\\u2010course versus prolonged\\u2010course antibiotic therapy for hospital\\u2010acquired pneumonia in critically ill adults",firstPublishedDate:"Aug 24, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Acute Respiratory Infections Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007577.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007577.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007577.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007577.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007577.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007577.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007577.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007577.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007577.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007577.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>10599 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007577.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0095"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0035"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0036"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0059"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-sec-0089"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/appendices#CD007577-sec-0100"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/table_n/CD007577StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/table_n/CD007577StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#CD007577-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Richard Pugh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#CD007577-cr-0003">Chris Grant</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#CD007577-cr-0004">Richard PD Cooke</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information#CD007577-cr-0005">Ged Dempsey</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information/en#CD007577-sec-0109">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 24 August 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007577.pub3">https://doi.org/10.1002/14651858.CD007577.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007577-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007577-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007577-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD007577-abs-0015">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007577-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007577-abs-0001" lang="en"> <section id="CD007577-sec-0001"> <h3 class="title" id="CD007577-sec-0001">Background</h3> <p>Pneumonia is the most common hospital‐acquired infection affecting patients in the intensive care unit (ICU). However, current national guidelines for the treatment of hospital‐acquired pneumonia (HAP) are several years old and the diagnosis of pneumonia in mechanically ventilated patients (VAP) has been subject to considerable recent attention. The optimal duration of antibiotic therapy for HAP in the critically ill is uncertain. </p> </section> <section id="CD007577-sec-0002"> <h3 class="title" id="CD007577-sec-0002">Objectives</h3> <p>To assess the effectiveness of short versus prolonged‐course antibiotics for HAP in critically ill adults, including patients with VAP. </p> </section> <section id="CD007577-sec-0003"> <h3 class="title" id="CD007577-sec-0003">Search methods</h3> <p>We searched CENTRAL (2015, Issue 5), MEDLINE (1946 to June 2015), MEDLINE in‐process and other non‐indexed citations (5 June 2015), EMBASE (2010 to June 2015), LILACS (1982 to June 2015) and Web of Science (1955 to June 2015). </p> </section> <section id="CD007577-sec-0004"> <h3 class="title" id="CD007577-sec-0004">Selection criteria</h3> <p>We considered all randomised controlled trials (RCTs) comparing a fixed 'short' duration of antibiotic therapy with a 'prolonged' course for HAP (including patients with VAP) in critically ill adults. </p> </section> <section id="CD007577-sec-0005"> <h3 class="title" id="CD007577-sec-0005">Data collection and analysis</h3> <p>Two review authors conducted data extraction and assessment of risk of bias. We contacted trial authors for additional information. </p> </section> <section id="CD007577-sec-0006"> <h3 class="title" id="CD007577-sec-0006">Main results</h3> <p>We identified six relevant studies involving 1088 participants. This included two new studies published after the date of our previous review (2011). There was substantial variation in participants, in the diagnostic criteria used to define an episode of pneumonia, in the interventions and in the reported outcomes. We found no evidence relating to patients with a high probability of HAP who were not mechanically ventilated. For patients with VAP, overall a short seven‐ or eight‐day course of antibiotics compared with a prolonged 10‐ to 15‐day course increased 28‐day antibiotic‐free days (two studies; N = 431; mean difference (MD) 4.02 days; 95% confidence interval (CI) 2.26 to 5.78) and reduced recurrence of VAP due to multi‐resistant organisms (one study; N = 110; odds ratio (OR) 0.44; 95% CI 0.21 to 0.95), without adversely affecting mortality and other recurrence outcomes. However, for cases of VAP specifically due to non‐fermenting Gram‐negative bacilli (NF‐GNB), recurrence was greater after short‐course therapy (two studies, N = 176; OR 2.18; 95% CI 1.14 to 4.16), though mortality outcomes were not significantly different. One study found that a three‐day course of antibiotic therapy for patients with suspected HAP but a low Clinical Pulmonary Infection Score (CPIS) was associated with a significantly lower risk of superinfection or emergence of antimicrobial resistance, compared with standard (prolonged) course therapy. </p> </section> <section id="CD007577-sec-0007"> <h3 class="title" id="CD007577-sec-0007">Authors' conclusions</h3> <p>On the basis of a small number of studies and appreciating the lack of uniform definition of pneumonia, we conclude that for patients with VAP not due to NF‐GNB a short, fixed course (seven or eight days) of antibiotic therapy appears not to increase the risk of adverse clinical outcomes, and may reduce the emergence of resistant organisms, compared with a prolonged course (10 to 15 days). However, for patients with VAP due to NF‐GNB, there appears to be a higher risk of recurrence following short‐course therapy. These findings do not differ from those of our previous review and are broadly consistent with current guidelines. There are few data from RCTs comparing durations of therapy in non‐ventilated patients with HAP, but on the basis of a single study, short‐course (three‐day) therapy for HAP appears not to be associated with worse clinical outcome, and may reduce the risk of subsequent infection or the emergence of resistant organisms when there is low probability of pneumonia according to the CPIS. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007577-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD007577-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007577-abs-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007577-abs-0013">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD007577-abs-0017">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007577-abs-0011">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007577-abs-0010">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD007577-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD007577-abs-0009">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD007577-abs-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007577-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007577-abs-0008">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007577-abs-0005" lang="en"> <h3>Short‐course versus long‐course antibiotic treatment for hospital‐acquired pneumonia in adult intensive care patients </h3> <p><b>Review question</b> <br/> We reviewed the evidence from randomised controlled trials (RCTs) that compared the effects of a short course of antibiotics with a long course for intensive care patients with hospital‐acquired pneumonia (HAP). </p> <p><b>Background</b> <br/> Hospital‐acquired pneumonia is the major cause of hospital‐acquired infection in the intensive care unit (ICU). There are a number of factors that make the critically ill more likely to develop pneumonia, among which the most important is tracheal intubation performed in conjunction with mechanical ventilation; thus, the majority of ICU patients with HAP have what is termed ventilator‐associated pneumonia (VAP). </p> <p>There is concern that an unnecessarily long course of antibiotic therapy may lead to patients acquiring antibiotic‐resistant organisms, which may be more difficult to recognise and treat when they cause infection and may increase drug costs. On the other hand, too short a course risks the treatment failing. </p> <p><b>Study characteristics</b> <br/> The evidence was current as of June 2015. We identified six RCTs, which had enrolled 1088 patients. The studies took quite different approaches to their investigations, and we found only one study that had explored the duration of antibiotic therapy for ICU patients who had HAP, but were not mechanically ventilated. </p> <p><b>Key results</b> <br/> For patients with VAP, our main finding was that a course of seven or eight days of antibiotics was associated with an overall decrease in antibiotic administration and reduced the recurrence of pneumonia due to resistant organisms when compared with a 10‐ to 15‐day course. Furthermore, this was achieved without any significant effect on mortality. Nevertheless, in cases when VAP was due to a particular type of organism ('non‐fermenting Gram‐negative bacillus'), which can be difficult to eradicate with antibiotics, the risk of pneumonia recurring appeared higher after a short course of treatment. </p> <p>One study found that for patients with possible (but low probability) HAP a short (three‐day) course of therapy seemed to be associated with a lower chance of acquiring resistant organisms or of subsequent infections being due to a resistant organism. </p> <p><b>Quality of evidence</b> <br/> The quality of evidence for the main outcome measures was low to moderate. The main reasons that the quality was not high were that only a small number of studies were identified, and that there were differences in patient populations, in the nature of the interventions between studies and in the reported outcomes. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007577-sec-0095" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-sec-0095">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-sec-0153">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007577-sec-0095"></div> <h3 class="title" id="CD007577-sec-0096">Implications for practice</h3> <section id="CD007577-sec-0096"> <p>Our review identified very few data regarding the appropriate duration of antibiotic therapy for intensive care unit (ICU) patients with hospital‐acquired pneumonia (HAP) who are not mechanically ventilated. However, where HAP is suspected (in mechanically or non‐mechanically ventilated patients), but there is a low probability of pneumonia according to clinical pulmonary infection score (CPIS), a fixed three‐day course of therapy appears to significantly reduce antibiotic administration, risk of emergence of resistant organisms or superinfection, and duration of ICU stay, according to a single study. </p> <p>On the basis of a very small number of studies of patients with ventilator‐associated pneumonia (VAP), adopting a seven‐ or eight‐day course of antibiotic therapy in the absence of non‐fermenting Gram‐negative bacilli (NF‐GNB) infection is associated with a significant increase in 28‐day antibiotic‐free days (two studies) and reduced VAP recurrence due to multi‐resistant organisms (one study), without adverse effects on overall recurrence or mortality, compared with a 10‐ to 15‐day course. </p> <p>However, for patients with VAP due to NF‐GNB organisms, a short eight‐day course is associated with a higher rate of VAP recurrence than a prolonged 12‐ to 15‐day course, on the basis of pooled data from two studies. This greater risk of recurrence does not appear to be associated with an increased mortality, or prolonged requirement for mechanical ventilation or duration of ICU stay. </p> <p>The single study utilising an extended infusion of antibiotics according to pharmaco‐dynamic/kinetic profile for Gram‐negative VAP did not demonstrate superior clinical outcomes. </p> <p>There is a notable lack of data regarding emergence of <i>C. difficile</i>‐related infection with different antibiotic strategies. </p> <p>In summary, use of short‐course (seven‐ to eight‐day) therapy for VAP is likely to reduce antibiotic exposure in the critically ill, with reduced emergence of resistant organisms, and potential for reduction in antibiotic‐associated morbidity and cost savings, but is unlikely to be appropriate for all patients with VAP due to NF‐GNB. Appreciating the current lack of data, these findings appear broadly to support current guidelines (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>; <a href="./references#CD007577-bbs2-0041" title="MastertonRG ,  GallowayA ,  FrenchG ,  StreetM ,  ArmstrongJ ,  BrownE ,  etal . Guidelines for the management of hospital‐acquired pneumonia in the UK: report of the working party on hospital‐acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy2008;62(1):5‐34. ">BSAC 2008</a>; <a href="./references#CD007577-bbs2-0083" title="RotsteinC , EvansG , BornA , GrossmanR , LightRB , MagderS , et al. Clinical practice guidelines for hospital‐acquired pneumonia and ventilator‐associated pneumonia in adults. Canadian Journal of Infectious Diseases and Medical Microbiology2008;19(1):19‐53. ">Rotstein 2008</a>). </p> </section> <h3 class="title" id="CD007577-sec-0097">Implications for research</h3> <section id="CD007577-sec-0097"> <p>There are inadequate data regarding the appropriate duration of antibiotic therapy for HAP in non‐mechanically ventilated patients; characteristics differ sufficiently between this group and those with VAP for this to warrant further research. However, even for patients with VAP, there are very few randomised controlled trials (RCTs) evaluating strategies intended to limit unnecessary antibiotic treatment. </p> <p>The relative merits of fixed short versus prolonged‐course antibiotic therapy have been under‐explored, and the optimal duration of therapy for patients with NF‐GNB VAP is particularly unclear. The literature on this topic is still dominated by the Pneuma study, which was published over a decade ago. </p> <p>Major differences in definitions of pneumonia were evident in these studies, and arguably there is a need for greater standardisation. The relationship between a historically defined episode of ICU‐acquired pneumonia (using clinical, radiographic and microbiological criteria) and newer surveillance definitions (i.e. the new Centers for Disease Control and Prevention (CDC) ventilator‐associated event classification) appears to need further exploration. Currently, the clinical utility of these newly defined conditions is unproven and optimal antibiotic use in the context of "possible VAP" (PVAP) or infection‐related ventilator‐associated condition (I‐VAC), for example, is not clear. </p> <p>Short‐course therapy does not appear to be appropriate for all patients with VAP due to NF‐GNB, and clinical response to treatment may be at variance with bacterial persistence. Further research to explore the value of continued antibiotic administration beyond seven to eight days for NF‐GNB VAP is necessary. The relationships between bacterial persistence (which in turn may be related to virulence factors), clinical response (e.g. according to Clinical Pulmonary Infection Score) and relevant biomarkers (e.g. procalcitonin) should be explored in more detail for VAP due to NF‐GNB, and ideally reported according to standardised outcome measures (e.g. 28‐day relapse, mortality, mechanical ventilation‐free days and antibiotic‐free days). There is a current lack of data regarding the emergence of <i>C. difficile</i>‐related disease with different antibiotic strategies in the critically ill. Furthermore, there appears to be scope to explore the appropriate duration of therapy for NF‐GNB VAP according to use of class or combination antibiotic therapy, extended administration according to pharmaco‐dynamic/kinetic profile, and novel methods of administration (e.g. nebulised therapy). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007577-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007577-sec-0029"></div> <div class="table" id="CD007577-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Should short‐course antibiotic therapy versus prolonged‐course antibiotic therapy be used in critically ill patients with hospital‐acquired pneumonia?</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Should short‐course antibiotic therapy versus prolonged‐course antibiotic therapy be used in critically ill patients with hospital‐acquired pneumonia? </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> hospital‐acquired pneumonia<br/> <b>Settings:</b> intensive care<br/> <b>Intervention:</b> short‐course antibiotic therapy<br/> <b>Comparison:</b> prolonged‐course antibiotic therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Prolonged‐course antibiotic therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Short‐course antibiotic therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>201 per 1000</b> <br/> (141 to 277) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.18</b> <br/> (0.77 to 1.8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>598<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality NF‐GNB</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>265 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> <br/> (123 to 450) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.95</b> <br/> (0.39 to 2.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>179<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality MRSA</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>238 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>286 per 1000</b> <br/> (91 to 614) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.28</b> <br/> (0.32 to 5.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence of pneumonia</b> <br/> Clinical and/or microbiological criteria </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>180 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>237 per 1000</b> <br/> (171 to 318) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.41</b> <br/> (0.94 to 2.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>733<br/> (19 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence of pneumonia NF‐GNB</b> <br/> Clinical and/or microbiological criteria </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>417 per 1000</b> <br/> (272 to 577) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 2.18</b> <br/> (1.14 to 4.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence of pneumonia MRSA</b> <br/> Clinical and/or microbiological criteria </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>370 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>479 per 1000</b> <br/> (66 to 920) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.56</b> <br/> (0.12 to 19.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>28‐day antibiotic‐free days</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>The mean 28‐day antibiotic free days in the intervention groups was<br/> <b>4.02 higher</b> <br/> (2.26 to 5.78 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>MRSA:</b> methicillin‐resistant <i>Staphylococcus aureus</i>; <b>NF‐GNB:</b> non‐fermenting Gram‐negative bacilli; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Low total number of events.<br/> <sup>2</sup>Kollef et al. Multiple interventions (short versus prolonged duration, doripenem versus imipenem, extended versus standard infusion), protocol violations at several centres and premature cessation of study.<br/> <sup>3</sup>Differences in duration of mechanical ventilation prior to episode of pneumonia and differences in bacterial aetiology.<br/> <sup>4</sup>Presumed differences in administration of antibiotics (outside of context of study) between studies. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007577-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-sec-0118">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD007577-sec-0030"></div> <section id="CD007577-sec-0031"> <h3 class="title" id="CD007577-sec-0031">Description of the condition</h3> <p>Hospital‐acquired pneumonia (HAP) is usually defined as pneumonia occurring 48 hours or more after hospital admission and not incubating at time of admission (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>). It remains an important cause of healthcare‐associated morbidity and mortality, occurring among the general hospitalised population with a rate of 5 to 10 per 1000 hospital admissions (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>). Patients in the intensive care unit (ICU, also referred to as intensive therapy unit, ITU) appear to be at particular risk and in this setting pneumonia is the most common cause of hospital‐acquired infection in Europe and the United States (<a href="./references#CD007577-bbs2-0042" title="BurgmannH , HiesmayerJ , SaveyA , BauerP , MetnitzB , MetnitzP . Impact of nosocomial infections on clinical outcome and resource consumption in critically ill patients. Intensive Care Medicine2010;36:1597‐601. ">Burgmann 2010</a>; <a href="./references#CD007577-bbs2-0082" title="RichardsMJ , EdwardsJR , CulverDH , GaynesRP . Nosocomial infections in combined medical‐surgical intensive care units in the United States. Infection Control and Hospital Epidemiology2000;21(8):510‐5. ">Richards 2000</a>; <a href="./references#CD007577-bbs2-0091" title="VincentJL ,  BihariDJ ,  SuterPM ,  BruiningHA ,  WhiteJ ,  Nicolas‐ChanoinMH ,  etal . The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA1995;274(8):639‐44. ">Vincent 1995</a>). </p> <p>Over 90% of pneumonia episodes developing in ICUs occur in patients who are intubated and mechanically ventilated (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>); ventilator‐associated pneumonia (VAP) therefore represents a very significant sub‐set of HAP occurring in ICUs. VAP has been defined as pneumonia that occurs more than 48 to 72 hours after tracheal intubation (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>) and is thought to affect 10% to 20% patients receiving mechanical ventilation for more than 48 hours (<a href="./references#CD007577-bbs2-0084" title="SafdarN , DezfulianC , CollardHR , SaintS . Clinical and economic consequences of ventilator‐associated pneumonia: a systematic review. Critical Care Medicine2005;33:2184‐93. ">Safdar 2005</a>). Endotracheal intubation probably increases the risk of developing pneumonia by facilitating the growth of potential bacterial pathogens within the respiratory tract (<a href="./references#CD007577-bbs2-0044" title="ChastreJ , FagonJY . Ventilator‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2002;165:867‐903. ">Chastre 2002</a>). Patients are more likely to develop VAP if they are sicker, older, have undergone prior surgery, or are admitted with neurological and/or cardiovascular failure (<a href="./references#CD007577-bbs2-0039" title="BlotS , KoulentiD , DimopoulosG , MartinC , KomnosA , KruegerWA , et al. Prevalence, risk factors, and mortality for ventilator‐associated pneumonia in middle‐aged, old, and very old critically ill patients. Critical Care Medicine2014;42:601‐9. ">Blot 2013</a>; <a href="./references#CD007577-bbs2-0044" title="ChastreJ , FagonJY . Ventilator‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2002;165:867‐903. ">Chastre 2002</a>). Recently it has been suggested that 'ventilator‐associated tracheobronchitis' (VAT), i.e. ventilator‐associated respiratory tract infection in the absence of chest x‐ray changes, may be a precursor of VAP (<a href="./references#CD007577-bbs2-0047" title="DallasJ , SkrupkyL , AbebeN , BoyleW , KollefM . Ventilator‐associated tracheobronchitis in a mixed surgical and medical ICU population. Chest2011;139:513‐8. ">Dallas 2011</a>), and that antibiotic therapy may prevent an episode from developing into pneumonia (<a href="./references#CD007577-bbs2-0035" title="AgrafiotisM , SiemposII , FalagasME . Frequency, prevention, outcome and treatment of ventilator‐associated tracheobronchitis: systematic review and meta‐analysis. Respiratory Medicine2010;104:325‐36. ">Agrafiotis 2010</a>). </p> <p>An episode of HAP has adverse consequences for the critically ill. Mortality attributable to an episode of VAP (as opposed to the severe underlying illness) has been estimated to be 4% to 13% (<a href="./references#CD007577-bbs2-0037" title="BekaertM , TimsitJF , VansteelandtS , DepuydtP , VésinA , Garrouste‐OrgeasM , et al. Attributable mortality of ventilator‐associated pneumonia: a reappraisal using causal analysis. American Journal of Respiratory and Critical Care Medicine2011;184(10):133‐9. ">Bekaert 2011</a>; <a href="./references#CD007577-bbs2-0074" title="MelsenWG , RoversMM , KoemanM , BontenMJ . Estimating the attributable mortality of ventilator‐associated pneumonia from randomized prevention studies. Critical Care Medicine2011;39(12):2736‐42. ">Melsen 2011</a>; <a href="./references#CD007577-bbs2-0075" title="MelsenWG , RoversMM , GroenwoldRH , BergmansDC , CamusC , BauerTT , et al. Attributable mortality of ventilator‐associated pneumonia: a meta‐analysis of individual patient data from randomised prevention studies. Lancet Infectious Diseases2013;13(8):665‐71. ">Melsen 2013</a>). Furthermore, lengths of ICU and hospital stay are significantly prolonged when VAP develops and associated costs have been estimated to range from USD 10,000 to 40,000 per patient (<a href="./references#CD007577-bbs2-0079" title="RelloJ , OllendorfDA , OsterG , Vera‐LlonchM , BellmL , RedmanR , et al. Epidemiology and outcomes of ventilator‐associated pneumonia in a large US database. Chest2002;122:2115‐21. ">Rello 2002</a>; <a href="./references#CD007577-bbs2-0084" title="SafdarN , DezfulianC , CollardHR , SaintS . Clinical and economic consequences of ventilator‐associated pneumonia: a systematic review. Critical Care Medicine2005;33:2184‐93. ">Safdar 2005</a>; <a href="./references#CD007577-bbs2-0094" title="WarrenDK , ShuklaSJ , OlsenMA , KollefMH , HollenbeakCS , et al. Outcome and attributable cost of ventilator‐associated pneumonia among intensive care unit patients in a suburban medical center. Critical Care Medicine2003;31:1312‐7. ">Warren 2003</a>). </p> <p>Considerable effort has been made in recent years to refine VAP definitions, yet doubt remains as to the optimal means of identifying an episode of VAP for clinical and for surveillance purposes. Traditionally, radiological evidence of pneumonia, systemic criteria (e.g. pyrexia or abnormal white cell count) and/or pulmonary criteria (e.g. presence of bronchial breathing or worsening cough) have been required to make a diagnosis of VAP (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>; <a href="./references#CD007577-bbs2-0059" title="Hospital in Europe Link for Infection Control through Surveillance (HELICS). Surveillance of Nosocomial infections in intensive care units, Protocol Version 6.1. http://ecdc.europa.eu/en/activities/surveillance/HAI/Documents/0409_IPSE_ICU_protocol.pdf 2004 (accessed 9 January 2015). ">HELICS 2004</a>; <a href="./references#CD007577-bbs2-0061" title="HoranTC , AndrusM , DudeckMA . CDC/NHSN surveillance definition of health care‐associated infection and criteria for specific types of infections in the acute care setting. American Journal of Infection Control2008;36:309‐32. ">Horan 2008</a>). However, practically it can be very difficult to make a distinction between VAP and other conditions occurring in mechanically ventilated critically ill patients, including non‐infective processes such as atelectasis and pulmonary oedema. Quantitative culture of invasive bronchoscopic respiratory specimen (e.g. broncho‐alveolar lavage, BAL) may have particular appeal for diagnosing VAP in patient groups with greater likelihood of a non‐pulmonary cause for systemic inflammation (e.g. trauma or surgical patients, <a href="./references#CD007577-bbs2-0087" title="SharpeJP , MagnottiLJ , WeinbergJA , SwansonJM , SchroeppelTJ , ClementLP , et al. Adherence to an established diagnostic threshold for ventilator‐associated pneumonia contributes to low false‐negative rates in trauma patients. Journal of Trauma and Acute Care Surgery2015;78(3):468‐73. ">Sharpe 2015</a>), and may reduce antibiotic prescription (<a href="./references#CD007577-bbs2-0046" title="MorrisAC , KefalaK , SimpsonAJ , WilkinsonTS , EveringhamK , KerslakeD , et al. Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator‐associated pneumonia. Thorax2011;64:516‐22. ">Conway Morris 2011</a>; <a href="./references#CD007577-bbs2-0011" title="FagonJY , ChastreJ , WolffM , GervaisC , Parer‐AubasS , StéphanF , et al. Invasive and noninvasive strategies for management of suspected ventilator‐associated pneumonia. A randomized trial. Annals of Internal Medicine2000;132(8):621‐30. ">Fagon 2000</a>), but is not often performed in European units (<a href="./references#CD007577-bbs2-0069" title="KoulentiD , LisboaT , Brun‐BuissonC , KruegerW , MacorA , Sole‐ViolanJ , et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Critical Care Medicine2009;37:2360‐8. ">Koulenti 2009</a>). Indeed, there may be variable tendency to perform chest radiography before starting a course of antibiotics for suspected ICU‐acquired respiratory tract infection (<a href="./references#CD007577-bbs2-0090" title="SzakmanyT , HarrisonW , RobertsH , ScholeyG , PughR . Surveillance for ventilator‐associated pneumonia (VAP) in Wales: is HELICS the best way?. Critical Care Medicine2013;41(Suppl 12):46. ">Szakmany 2013</a>), and disagreement on the presence or absence of radiographic signs (<a href="./references#CD007577-bbs2-0095" title="WunderinkR . Radiologic diagnosis of ventilator‐associated pneumonia. Chest 117;117(Suppl):188‐90. ">Wunderink 2000</a>), or clinical pulmonary features. </p> <p>The Centers for Disease Control and Prevention's National Healthcare Safety Network (CDC/NHSN) have lately attempted to improve the reliability of surveillance for ventilator‐associated morbidity in the United States, concentrating on objective criteria (i.e. changes in oxygenation, inflammatory markers, the initiation of antibiotics and positive microbiology) and introducing a classification of "ventilator‐associated events" (VAEs) (<a href="./references#CD007577-bbs2-0072" title="MagillS , KlompasM , BalkR , BurnsSM , DeutschmanC , DiekemaD , et al. Developing a new, national approach to surveillance for ventilator‐associated events. Critical Care Medicine2013;41:2467‐75. ">Magill 2013</a>), of which "possible VAP [PVAP]" now represents one example. Some concern has been raised at this relatively early stage that although developing a "ventilator‐associated complication" (VAC) on the basis of worse oxygenation may predict poorer clinical outcome (<a href="./references#CD007577-bbs2-0040" title="BoyerAF , SchoenbergN , BabcockH , McMullenKM , MicekST , KollefMH . A prospective evaluation of ventilator‐associated conditions and infection‐related ventilator‐associated conditions. Chest2015;147:68‐81. ">Boyer 2015</a>; <a href="./references#CD007577-bbs2-0058" title="HayashiY , MorisawaK , KlompasM , JonesM , BandesheH , BootsR , et al. Toward improved surveillance: the impact of ventilator‐associated complications on length of stay and antibiotic use in patients in intensive care units. Clinical Infectious Disease2013;56:471‐7. ">Hayashi 2013</a>; <a href="./references#CD007577-bbs2-0064" title="Klein KlouwenbergP , vanMourikM , OngD , HornJ , SchultzM , CremerO , et al. Electronic implementation of a novel surveillance paradigm for ventilator‐associated events. Feasibility and validation. American Journal of Respiratory and Critical Care Medicine2014;189:947‐55. ">Klein Klouwenberg 2014</a>; <a href="./references#CD007577-bbs2-0077" title="MuscedereJ , SinuffT , HeylandD , DodekP , KeenanS , WoodG , et al. The clinical impact and preventability of ventilator‐associated conditions in critically ill patients who are mechanically ventilated. Chest2013;144:1453‐60. ">Muscedere 2013</a>), the overlap between an episode of VAC (defined according to surveillance needs) and an episode of historically defined VAP (according to the radiographic, clinical and microbiological criteria) appears to be limited (<a href="./references#CD007577-bbs2-0040" title="BoyerAF , SchoenbergN , BabcockH , McMullenKM , MicekST , KollefMH . A prospective evaluation of ventilator‐associated conditions and infection‐related ventilator‐associated conditions. Chest2015;147:68‐81. ">Boyer 2015</a>; <a href="./references#CD007577-bbs2-0058" title="HayashiY , MorisawaK , KlompasM , JonesM , BandesheH , BootsR , et al. Toward improved surveillance: the impact of ventilator‐associated complications on length of stay and antibiotic use in patients in intensive care units. Clinical Infectious Disease2013;56:471‐7. ">Hayashi 2013</a>; <a href="./references#CD007577-bbs2-0064" title="Klein KlouwenbergP , vanMourikM , OngD , HornJ , SchultzM , CremerO , et al. Electronic implementation of a novel surveillance paradigm for ventilator‐associated events. Feasibility and validation. American Journal of Respiratory and Critical Care Medicine2014;189:947‐55. ">Klein Klouwenberg 2014</a>; <a href="./references#CD007577-bbs2-0077" title="MuscedereJ , SinuffT , HeylandD , DodekP , KeenanS , WoodG , et al. The clinical impact and preventability of ventilator‐associated conditions in critically ill patients who are mechanically ventilated. Chest2013;144:1453‐60. ">Muscedere 2013</a>; <a href="./references#CD007577-bbs2-0089" title="StoeppelCM , ErikssonEA , HawkinsK , EastmanA , WolfS , MineiJ , et al. Applicability of the National Healthcare Safety Network's surveillance definition of ventilator‐associated events in the surgical intensive care unit: a 1‐year review. Journal of Trauma and Acute Care Surgery2014;77:934‐7. ">Stoeppel 2014</a>). The potential utility of these newly defined conditions with respect to antibiotic prescription at the bedside is uncertain (<a href="./references#CD007577-bbs2-0063" title="KipnisE , NseirS . Ventilator‐associated events (VAEs): VAE Victis? (Woe to the conquered?)*. Critical Care Medicine2014;42(8):1949‐50. ">Kipnis 2014</a>). </p> </section> <section id="CD007577-sec-0032"> <h3 class="title" id="CD007577-sec-0032">Description of the intervention</h3> <p>A number of strategies to guide duration of antibiotic therapy in the treatment of HAP for the critically ill have been described. Antibiotics administered according to a fixed duration is the focus of this review (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0013" title="IbrahimEH ,  WardS ,  ShermanG ,  SchaiffR ,  FraserVJ ,  KollefMH . Experience with a clinical guideline for the treatment of ventilator‐associated pneumonia. Critical Care Medicine2001;29(6):1109‐15. ">Ibrahim 2001</a>). National guidelines published within the last decade have recommended a course of antibiotic therapy for HAP of up to eight days when there has been good response to therapy (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>; <a href="./references#CD007577-bbs2-0041" title="MastertonRG ,  GallowayA ,  FrenchG ,  StreetM ,  ArmstrongJ ,  BrownE ,  etal . Guidelines for the management of hospital‐acquired pneumonia in the UK: report of the working party on hospital‐acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy2008;62(1):5‐34. ">BSAC 2008</a>), but a prolonged course of two to three weeks if response has been poor, or when infection is due to a non‐fermenting Gram‐negative bacillus (NF‐GNB), such as <i>Pseudomonas aeruginosa</i> (<i>P. aeruginosa</i>) (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>), an organism particularly difficult to eradicate from the respiratory tract despite in vitro sensitivity to antibiotic therapy (<a href="./references#CD007577-bbs2-0049" title="DennesenPJ , van derVenAJ , KesselsAG , RamsayG , BontenMJ . Resolution of infectious parameters after antimicrobial therapy in patients with ventilator‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2001;163(6):1371‐5. ">Dennesen 2001</a>; <a href="./references#CD007577-bbs2-0093" title="VisscherS , SchurinkCA , MelsenWG , LucasPJ , BontenMJ . Effects of systemic antibiotic therapy on bacterial persistence in the respiratory tract of mechanically ventilated patients. Intensive Care Medicine2008;34(4):692‐9. ">Visscher 2008</a>), and an independent risk factor for VAP recurrence and mortality (<a href="./references#CD007577-bbs2-0045" title="CombesA , LuytCE , FagonJY , WolffM , TrouilletJL , ChastreJ . Early predictors for infection recurrence and death in patients with ventilator‐associated pneumonia. Critical Care Medicine2007;35(1):146‐54. ">Combes 2007</a>; <a href="./references#CD007577-bbs2-0066" title="KollefMH , SilverP , MurphyDM , TrovillionE . The effect of late‐onset ventilator‐associated pneumonia in determining patient mortality. Chest1995;108(6):1655‐62. ">Kollef 1995</a>)<i>.</i> </p> <p>Other strategies to limit duration of antibiotic therapy were explored in a previous version of this review (<a href="./references#CD007577-bbs2-0098" title="PughR , GrantC , CookeRPD , DempseyG . Short‐course versus prolonged‐course antibiotic therapy for hospital‐acquired pneumonia in critically ill adults. Cochrane Database of Systematic Reviews2011, Issue 10. [DOI: 10.1002/14651858.CD007577.pub2] ">Pugh 2011</a>). Such strategies may individualise and discontinue therapy according to resolution of clinical features (<a href="./references#CD007577-bbs2-0019" title="MicekST ,  WardS ,  FraserVJ ,  KollefMH . A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator‐associated pneumonia. Chest2004;125(5):1791‐9. ">Micek 2004</a>), to microbiological criteria (e.g. quantitative reduction in culture of respiratory specimens; <a href="./references#CD007577-bbs2-0076" title="MuellerEW ,  CroceMA ,  BoucherBA ,  HanesSD ,  WoodGC ,  SwansonJM ,  etal . Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator‐associated pneumonia. Journal of Trauma2007;63(6):1329‐37. ">Mueller 2007</a>) or to a relevant biomarker, such as procalcitonin (<a href="./references#CD007577-bbs2-0007" title="BouadmaL , LuytCE , TubachF , CraccoC , AlvarezA , SchwebelC , et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet2010;375(9713):463‐74. ">Bouadma 2010</a>; <a href="./references#CD007577-bbs2-0028" title="StolzD ,  SmyrniosN ,  EggimannP ,  ParggerH ,  ThakkarN ,  SiegemundM ,  etal . Procalcitonin for reduced antibiotic exposure in ventilator‐associated pneumonia: a randomised study. European Respiratory Journal2009;34(6):1364‐75. ">Stolz 2009a</a>). Studies of procalcitonin‐guided antibiotic therapy in critically ill patients (e.g. <a href="./references#CD007577-bbs2-0007" title="BouadmaL , LuytCE , TubachF , CraccoC , AlvarezA , SchwebelC , et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet2010;375(9713):463‐74. ">Bouadma 2010</a>; <a href="./references#CD007577-bbs2-0062" title="JensenJU , HeinL , LundgrenB , BestleMH , MohrTT , AndersenMH , et al. Procalcitonin‐guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: a randomized trial. Critical Care Medicine2011;39:2048‐58. ">Jensen 2011</a>; <a href="./references#CD007577-bbs2-0020" title="NobreV , HarbarthS , GrafJD , RohnerP , PuginJ . Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. American Journal of Respiratory and Critical Care Medicine2008;177(5):498‐505. ">Nobre 2008</a>; <a href="./references#CD007577-bbs2-0028" title="StolzD ,  SmyrniosN ,  EggimannP ,  ParggerH ,  ThakkarN ,  SiegemundM ,  etal . Procalcitonin for reduced antibiotic exposure in ventilator‐associated pneumonia: a randomised study. European Respiratory Journal2009;34(6):1364‐75. ">Stolz 2009a</a>) have been explored in recent dedicated systematic reviews of patients with sepsis (<a href="./references#CD007577-bbs2-0068" title="KopteridesP , SiemposII , TsangarisI , TsantesA , ArmaganidisA . Procalcitonin‐guided algorithms of antibiotic therapy in the intensive care unit: a systematic review and meta‐analysis of randomized controlled trials. Critical Care Medicine2010;38(11):2229‐41. ">Kopterides 2010</a>) and acute respiratory tract infection (<a href="./references#CD007577-bbs2-0085" title="SchuetzP , BrielM , Christ‐CrainM , StolzD , BouadmaL , WolffM , et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta‐analysis. Clinical Infectious Diseases2012;55:651‐62. ">Schuetz 2012a</a>; <a href="./references#CD007577-bbs2-0086" title="SchuetzP , MüllerB , Christ‐CrainM , StolzD , TammM , BouadmaL , et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database of Systematic Reviews2012, Issue 9. [DOI: 10.1002/14651858.CD007498.pub2] ">Schuetz 2012b</a>). Of further interest is the recently reported use of extended infusion administration (e.g. <a href="./references#CD007577-bbs2-0043" title="ChantC , LeungA , FriedrichJO . Optimal dosing of antibiotics in critically ill patients by using continuous/extended infusions: a systematic review and meta‐analysis. Critical Care2012;17:R279. ">Chant 2012</a>) and novel methods of administration, e.g. nebulisation (e.g. <a href="./references#CD007577-bbs2-0078" title="NiedermanMS , ChastreJ , CorkeryK , FinkJB , LuytCE , GarcíaMS . BAY41‐6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram‐negative pneumonia. Intensive Care Medicine2012;38:263‐71. ">Niederman 2012</a>). </p> </section> <section id="CD007577-sec-0033"> <h3 class="title" id="CD007577-sec-0033">How the intervention might work</h3> <p>Resolution of clinical abnormalities associated with VAP is often observed within the first week of antibiotic therapy (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0049" title="DennesenPJ , van derVenAJ , KesselsAG , RamsayG , BontenMJ . Resolution of infectious parameters after antimicrobial therapy in patients with ventilator‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2001;163(6):1371‐5. ">Dennesen 2001</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>), particularly among ICU survivors (<a href="./references#CD007577-bbs2-0071" title="LunaCM ,  BlanzacoD ,  NiedermanMS ,  MataruccoW ,  BaredesNC ,  DesmeryP ,  etal . Resolution of ventilator‐associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Critical Care Medicine2003;31(3):676‐82. ">Luna 2003</a>). For those that have responded to treatment, further prolongation of antibiotic therapy could lead to emergence of resistant organisms (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0049" title="DennesenPJ , van derVenAJ , KesselsAG , RamsayG , BontenMJ . Resolution of infectious parameters after antimicrobial therapy in patients with ventilator‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2001;163(6):1371‐5. ">Dennesen 2001</a>), may increase the risk of developing <i>Clostridium difficile</i> (<i>C. difficile</i>)‐associated disease (<a href="./references#CD007577-bbs2-0038" title="BignardiGE . Risk factors for Clostridium difficile infection. Journal of Hospital Infection1998;40(1):1‐15. ">Bignardi 1998</a>; <a href="./references#CD007577-bbs2-0051" title="DubberkeE , CarlingP , CarricoR , DonskeyC , LooV , McDonaldL , et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update. Infection Control and Hospital Epidemiology2014;35:628‐45. ">Dubberke 2014</a>) and antibiotic‐related toxicity, and will increase pharmacy costs. </p> </section> <section id="CD007577-sec-0034"> <h3 class="title" id="CD007577-sec-0034">Why it is important to do this review</h3> <p>Globally, nearly three‐quarters of ICU patients receive antibiotic therapy (<a href="./references#CD007577-bbs2-0092" title="VincentJL ,  RelloJ ,  MarshallJ ,  SilvaE ,  AnzuetoA ,  MartinCD ,  etal . International study of the prevalence and outcomes of infection in intensive care units. JAMA2009;302(21):2323‐9. ">Vincent 2009</a>), and when prescribed to treat infection (as opposed to prophylaxis) the focus is directed overwhelmingly at the respiratory tract (<a href="./references#CD007577-bbs2-0092" title="VincentJL ,  RelloJ ,  MarshallJ ,  SilvaE ,  AnzuetoA ,  MartinCD ,  etal . International study of the prevalence and outcomes of infection in intensive care units. JAMA2009;302(21):2323‐9. ">Vincent 2009</a>). Appropriate duration of antibiotic therapy is a key consideration in the optimal antimicrobial management (or antibiotic stewardship) of critically ill patients with HAP (<a href="./references#CD007577-bbs2-0067" title="KollefMH , MicekST . Antimicrobial stewardship programs: mandatory for all ICUs. Critical Care2012;16(6):179. ">Kollef 2012b</a>); too short a course of therapy risks treatment failure, whereas too long a course of therapy carries unnecessary costs and poses potential risks for the individual patient and to other patients through the emergence of resistant organisms. </p> <p>The optimal duration of antibiotic therapy for HAP (including VAP) in the critically ill is uncertain. Furthermore, when HAP is due to NF‐GNB, such as <i>P. aeruginosa</i>, the potential risk of treatment failure following short‐course therapy may be greater. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007577-sec-0035" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-sec-0035">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-sec-0123">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007577-sec-0035"></div> <p>To assess the effectiveness of short versus prolonged‐course antibiotics for HAP in critically ill adults, including patients with ventilator‐associated pneumonia (VAP). </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007577-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-sec-0124">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007577-sec-0036"></div> <section id="CD007577-sec-0037"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007577-sec-0038"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs) comparing a 'short' versus 'prolonged' course of antibiotic therapy for clinical and microbiological outcomes in critically ill patients with established HAP (including VAP). </p> </section> <section id="CD007577-sec-0039"> <h4 class="title">Types of participants</h4> <p>ICU patients (16 years and older) with HAP (including VAP) diagnosed by clinical and/or radiological features and/or quantitative culture of respiratory specimens. We excluded data regarding patients with haematological malignancy, chemically induced immune suppression or HIV/AIDS where possible. </p> </section> <section id="CD007577-sec-0040"> <h4 class="title">Types of interventions</h4> <p>RCTs comparing a fixed 'short' (eight days or less) duration of antibiotic therapy with a 'prolonged' (including standard care) course of antibiotic therapy. </p> </section> <section id="CD007577-sec-0041"> <h4 class="title">Types of outcome measures</h4> <section id="CD007577-sec-0042"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD007577-list-0001"> <li> <p>28‐day mortality.</p> </li> <li> <p>Recurrence of pneumonia (diagnosed on the basis of clinical and/or microbiological criteria). </p> </li> <li> <p>28‐day antibiotic‐free days.</p> </li> </ol> </p> </section> <section id="CD007577-sec-0043"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD007577-list-0002"> <li> <p>ICU mortality.</p> </li> <li> <p>In‐hospital mortality.</p> </li> <li> <p>Clinical resolution of pneumonia (according to clinical and/or microbiological criteria).</p> </li> <li> <p>Relapse of pneumonia.</p> </li> <li> <p>Subsequent infection due to 'resistant organisms' (for example, methicillin‐resistant <i>Staphylococcus aureus</i> (<i>S. aureus</i>) (MRSA)). </p> </li> <li> <p>Duration of ICU stay.</p> </li> <li> <p>Duration of hospital stay.</p> </li> <li> <p>Duration of mechanical ventilation (where appropriate).</p> </li> <li> <p>Mechanical ventilation‐free days (where appropriate).</p> </li> <li> <p>Mortality attributable to HAP.</p> </li> </ol> </p> </section> </section> </section> <section id="CD007577-sec-0044"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007577-sec-0045"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2015, Issue 5), MEDLINE (1946 to 2015), MEDLINE in‐process and other non‐indexed citations (5 June 2015), EMBASE (to June 2015), LILACS (1982 to June 2015) and Web of Science (1955 to June 2015). </p> <p>We used the search strategy described in <a href="./appendices#CD007577-sec-0101">Appendix 1</a> to search MEDLINE and CENTRAL. We combined the MEDLINE search strategy with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision); Ovid format (<a href="./references#CD007577-bbs2-0070" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6. Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Lefebvre 2011</a>). We modified these terms to search EMBASE (<a href="./appendices#CD007577-sec-0102">Appendix 2</a>), LILACS (<a href="./appendices#CD007577-sec-0103">Appendix 3</a>) and Web of Science (<a href="./appendices#CD007577-sec-0104">Appendix 4</a>). We imposed no publication or language restrictions. </p> </section> <section id="CD007577-sec-0046"> <h4 class="title">Searching other resources</h4> <p>We also searched the World Health Organization (WHO) International Clinical Trials Platform registers of controlled clinical trials, clinicaltrials.gov and the UK Clinical Trials Gateway (5 June 2015). We searched the Database of Abstracts of Reviews of Effects (DARE) for additional reviews. We searched reference lists of identified studies and review papers, and the OpenGrey database of grey literature. We also searched abstracts of recent conferences: International Symposium for Intensive Care and Emergency Medicine, European Society for Intensive Care Medicine, Society of Critical Care Medicine, American Thoracic Society, British Thoracic Society, European Respiratory Society, Chest, Infectious Disease Society of America and Interscience Conference on Antimicrobial Agents, and Chemotherapy. </p> </section> </section> <section id="CD007577-sec-0047"> <h3 class="title" id="CD007577-sec-0047">Data collection and analysis</h3> <section id="CD007577-sec-0048"> <h4 class="title">Selection of studies</h4> <p>Two review authors (RP, CG) independently analysed and reviewed the titles and abstracts of retrieved records for possible inclusion in this review. We used the following inclusion criteria: RCT, participants included ICU patients with HAP, comparison of fixed 'short' (eight days or less) duration of antibiotic therapy with 'prolonged' course antibiotic therapy, and relevant outcome data. We attempted to contact trial authors to clarify methods where indicated. We resolved any disagreements about study inclusion through consensus and, where needed, we involved a third review author (GD). </p> </section> <section id="CD007577-sec-0049"> <h4 class="title">Data extraction and management</h4> <p>We used a standardised data extraction form. Two review authors (RP, CG) extracted data and entered these data into a Review Manager (RevMan) document (<a href="./references#CD007577-bbs2-0081" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We contacted trial authors for any missing data. </p> </section> <section id="CD007577-sec-0050"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (RP, GD) independently assessed the validity of studies using the Cochrane 'Risk of bias' tool (<a href="./references#CD007577-bbs2-0088" title="SterneJAC , EggerM , MoherD (editors) . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Sterne 2011</a>). We resolved disagreements through consensus. </p> </section> <section id="CD007577-sec-0051"> <h4 class="title">Measures of treatment effect</h4> <p>We used the following dichotomous data for measuring treatment effect:</p> <p> <ul id="CD007577-list-0003"> <li> <p>mortality;</p> </li> <li> <p>clinical resolution;</p> </li> <li> <p>recurrence;</p> </li> <li> <p>relapse;</p> </li> <li> <p>infection with 'resistant organism'.</p> </li> </ul> </p> <p>In addition, we collected the following continuous data:</p> <p> <ul id="CD007577-list-0004"> <li> <p>durations of stay;</p> </li> <li> <p>duration of mechanical ventilation;</p> </li> <li> <p>ventilation‐ and antibiotic‐free days.</p> </li> </ul> </p> </section> <section id="CD007577-sec-0052"> <h4 class="title">Unit of analysis issues</h4> <p>We did not identify significant unit of analysis issues (for example, randomisation of a group of individuals rather than an individual in a cluster‐randomised trial, or allocation of an individual to multiple interventions in a cross‐over trial). </p> </section> <section id="CD007577-sec-0053"> <h4 class="title">Dealing with missing data</h4> <p>All studies presented data on the basis of the intention‐to‐treat (ITT) principle, i.e. all patients included in the study at the point of randomisation were analysed according to their assigned treatment group, regardless of whether or not treatment was completed. </p> </section> <section id="CD007577-sec-0054"> <h4 class="title">Assessment of heterogeneity</h4> <p>We anticipated sources of heterogeneity relating to: participation factors (preceding durations of hospitalisation and mechanical ventilation, bacterial pathogen, prior antibiotic administration and illness severity) and intervention factors (class of antibiotic and method of administration). We anticipated that methodological diversity would be a significant source of heterogeneity. We assessed heterogeneity on the basis of the I<sup>2</sup> statistic, interpreting a value below 40% as not suggestive of important heterogeneity (<a href="./references#CD007577-bbs2-0060" title="HigginsJP , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21:1539‐58. ">Higgins 2002</a>). </p> </section> <section id="CD007577-sec-0055"> <h4 class="title">Assessment of reporting biases</h4> <p>We attempted to minimise reporting bias by searching for unpublished trials and references to trial registries. Due to the small number of studies identified, we did not perform funnel plot tests for funnel plot asymmetry. </p> </section> <section id="CD007577-sec-0056"> <h4 class="title">Data synthesis</h4> <p>We used the mean difference (MD) as a summary statistic for continuous measures and the odds ratio (OR) for dichotomous measures. We chose a random‐effects model for meta‐analysis given the clinical and methodological diversity of studies, and limited scope to explore heterogeneity through subgroup analysis. </p> </section> <section id="CD007577-sec-0057"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>A priori subgroups were:</p> <p> <ul id="CD007577-list-0005"> <li> <p>duration of hospitalisation prior to development of pneumonia;</p> </li> <li> <p>ventilator‐ and non‐ventilator‐associated HAP;</p> </li> <li> <p>duration of mechanical ventilation prior to development of pneumonia;</p> </li> <li> <p>administration of antibiotic therapy during hospital admission prior to development of pneumonia; </p> </li> <li> <p>severity of illness;</p> </li> <li> <p>chronic respiratory illness;</p> </li> <li> <p>bacterial pathogen: NF‐GNB and MRSA;</p> </li> <li> <p>class of antibiotic(s).</p> </li> </ul> </p> <p>However, outcome data were insufficiently reported for individual subgroups to enable investigation of sources of heterogeneity with the exception of bacterial pathogen. </p> <p>We did not perform meta‐regression owing to the low number of included studies (<a href="./references#CD007577-bbs2-0048" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> </section> <section id="CD007577-sec-0058"> <h4 class="title">Sensitivity analysis</h4> <p>We intended to perform sensitivity analysis if there were apparent differences in participants, interventions or methodology, irrespective of measures of study heterogeneity (I<sup>2</sup> statistic). </p> <p>The studies with which we had particular concerns in this respect were: <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> (since data has been published in abstract form only), <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> (since participants were specifically selected for likelihood of "early‐onset" ventilator‐associated pneumonia) and <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> (due to multiple differences between intervention measures), and on this basis, pooled results excluding data from these studies are presented in <a href="./appendices#CD007577-sec-0105">Appendix 5</a>. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007577-sec-0059" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007577-sec-0059"></div> <section id="CD007577-sec-0060"> <h3 class="title">Description of studies</h3> <section id="CD007577-sec-0061"> <h4 class="title">Results of the search</h4> <p>The searches of CENTRAL (2015, Issue 5), MEDLINE (Ovid) from 1946 to June 2015, MEDLINE in‐process and other non‐indexed citations to June 2015, EMBASE to June 2015, LILACS to June 2015 and Web of Science to June 2015 produced 5878 results (after removal of duplicates). Further searching of DARE within <i>The Cochrane Library</i> 2015, Issue 5 identified 131 records. Searches of additional databases produced the following: Clinical.Trials.gov 113 results, WHO International Clinical Trials Registry Platform 83 results, UK Clinical Trials Gateway one result. </p> <p>Of these, we undertook full‐text review of 12 potentially eligible studies (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0009" title="Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator‐associated pneumonia. New England Journal of Medicine2006;355(25):2619‐30. ">CCCTG 2006</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0010" title="ChastreJ , WolffM , FagonJY , ChevretS . Comparison of two durations of antibiotic therapy to treat ventilator‐associated pneumonia (VAP). American Thoracic Society Meeting, Seattle, Washington. 2003:A015. ">Chastre 2003b</a>; <a href="./references#CD007577-bbs2-0011" title="FagonJY , ChastreJ , WolffM , GervaisC , Parer‐AubasS , StéphanF , et al. Invasive and noninvasive strategies for management of suspected ventilator‐associated pneumonia. A randomized trial. Annals of Internal Medicine2000;132(8):621‐30. ">Fagon 2000</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0015" title="KimJW , ChungJ , ChoiSH , JangHJ , HongSB , LimCM , et al. Early use of imipenem/cilastatin and vancomycin followed by de‐escalation versus conventional antimicrobials without de‐escalation for patients with hospital‐acquired pneumonia in a medical ICU: a randomized clinical trial. Critical Care2012;16(1):R28. ">Kim 2012</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0019" title="MicekST ,  WardS ,  FraserVJ ,  KollefMH . A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator‐associated pneumonia. Chest2004;125(5):1791‐9. ">Micek 2004</a>; <a href="./references#CD007577-bbs2-0024" title="Sanchez‐NietoJM , TorresA , Garcia‐CordobaF , El‐EbiaryM , CarrilloA , RuizJ , et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator‐associated pneumonia: a pilot study. American Journal of Respiratory and Critical Care Medicine1998;157(2):371‐6. ">Sanchez‐Nieto 1998</a>; <a href="./references#CD007577-bbs2-0026" title="SinghN . Short‐course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU. Annual Meeting of the Infectious Disease Society of America, Denver, Colorado. 1998. ">Singh 1998</a>; <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>). We identified five other potential studies from review articles and reference lists (<a href="./references#CD007577-bbs2-0013" title="IbrahimEH ,  WardS ,  ShermanG ,  SchaiffR ,  FraserVJ ,  KollefMH . Experience with a clinical guideline for the treatment of ventilator‐associated pneumonia. Critical Care Medicine2001;29(6):1109‐15. ">Ibrahim 2001</a>; <a href="./references#CD007577-bbs2-0016" title="KollefMH ,  KollefKE . Antibiotic utilization and outcomes for patients with clinically suspected ventilator‐associated pneumonia and negative quantitative BAL culture results. Chest2005;128:2706‐13. ">Kollef 2005</a>; <a href="./references#CD007577-bbs2-0021" title="PeeryC , ChendrasekharA , MoormanDW , TimberlakeGA . Ventilator‐associated pneumonia therapy: protected specimen brushing versus tracheal aspirate data. Journal of Applied Research2001;1(2):1. ">Peery 2001</a>; <a href="./references#CD007577-bbs2-0023" title="RelloJ ,  VidaurL ,  SandiumengeA ,  RodríguezA ,  GualisB ,  BoqueC ,  etal . De‐escalation therapy in ventilator‐associated pneumonia. Critical Care Medicine2004;32(11):2183‐90. ">Rello 2004</a>; <a href="./references#CD007577-bbs2-0027" title="SoleVJ , FernandezJA , BenitezAB , Cardenosa CendreroJA , Rodriguez deCF . Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Critical Care Medicine2000;28(8):2737‐41. ">Sole 2000</a>). We found a further four studies on investigation of the 'grey literature', including relevant database searches and review of conference abstracts (<a href="./references#CD007577-bbs2-0017" title="LabelleAJ , SchoenbergN , SkrupkyL , KollefM . Five versus seven day antibiotic course for the treatment of pneumonia in the intensive care unit. American Journal of Respiratory and Critical Care Medicine. 2012; Vol. 185:A6078. ">Labelle 2012</a>; <a href="./references#CD007577-bbs2-0018" title="Maldonado‐OrtizEA , NiedermanMS , NaculF , RodríguezA , CeballosS , OsorioJ . How long is enough to treat ventilator associated pneumonia? A randomized pilot study: the Latinoamerican experience. Chest2004;126(Suppl 4):717. ">Maldonado‐Ortiz 2004</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>; <a href="./references#CD007577-bbs2-0031" title="WolffM , ChastreJ , FagonJY , ChevretS . Comparison of two durations of antibiotic therapy for ventilator‐associated pneumonia (VAP) caused by non‐fermenting gram negative bacilli (NF‐GNB). American Thoracic Society Meeting Seattle, Washington. 2003:A860. ">Wolff 2003</a>). Review of trials registers identified three potentially relevant ongoing studies (<a href="./references#CD007577-bbs2-0034" title="Duration of antibiotic treatment for early VAP. http://clinicaltrials.gov/show/NCT01994980 2013 (accessed 5 June, 2015). ">NCT01994980</a>; <a href="./references#CD007577-bbs2-0032" title="Effectiveness of short‐course versus standard antibiotic therapy in ICU patients. http://clinicaltrials.gov/ct2/show/study/NCT00410527 2006 (accessed 5 June, 2015). ">NCT00410527</a>; <a href="./references#CD007577-bbs2-0033" title="Five versus seven day antibiotic course for the treatment of pneumonia in the intensive care unit. https://clinicaltrials.gov/show/NCT01554657 2012 (accessed 5 June, 2015). ">NCT01554657</a>). </p> </section> <section id="CD007577-sec-0062"> <h4 class="title">Included studies</h4> <p>Six studies met the criteria for inclusion in this review, reporting data from a total of 1088 participants (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>; <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>). Summary data are presented in the <a href="./references#CD007577-sec-0115" title="">Characteristics of included studies</a> table. Of these, five were RCTs comparing fixed durations of antibiotic therapy in patients with VAP (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>). The sixth study was a RCT comparing short (three‐day) course therapy with 'standard' duration therapy for patients with a low probability of HAP, of whom only 58% were mechanically ventilated. There are substantial differences between this study and the others, and data from this study are therefore not included in meta‐analysis (<a href="./references#CD007577-bbs2-0026" title="SinghN . Short‐course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU. Annual Meeting of the Infectious Disease Society of America, Denver, Colorado. 1998. ">Singh 1998</a>). </p> <p>Of these six studies, only <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> appears to have been blinded, though details about blinding were not available for <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>. However, as discussed below, there is a potential significant source of bias in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>, since different antibiotic and antibiotic administration regimens were adopted for the seven‐day course (doripenem) and the 10‐day course (imipenem). </p> <section id="CD007577-sec-0063"> <h5 class="title">Participants</h5> <p>In terms of study size, the multi‐centre French Pneuma study dominates, having enrolled 401 participants (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>). A second multi‐centre French study (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>) and an international multi‐centre study (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>) recruited 225 and 274 participants, respectively, although in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> primary analysis is focused on the 167 participants fulfilling a "microbiological intention‐to‐treat (MITT)". A Uruguayan study, <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>, recruited 77 participants and has not yet, to our knowledge, been published in a peer‐reviewed journal. A smaller single‐centre Tunisian study, which recruited 30 participants, has been published in a French language journal (<a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>). The single‐centre US study by <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> enrolled 81 participants. </p> <p>With respect to patient characteristics, the Pneuma study was specifically designed to compare durations of antibiotic therapy in a population likely to have a high proportion of more resistant bacteria, including NF‐GNB such as <i>P. aeruginosa</i>, by excluding participants with early VAP (within the first five days of mechanical ventilation) and no antimicrobial therapy within the preceding 15 days (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>); 33% cases of VAP were due to NF‐GNB, and 11% due to MRSA. <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> intended to study participants with late‐onset VAP and for the "MITT" group to include only patients with Gram‐negative VAP; of this MITT group, 31% cases of VAP were due to mono‐microbial NF‐GNB; there were no cases of mono‐microbial MRSA VAP, but in 6.6% of cases MRSA was identified with another Gram‐negative organism. Higher proportions of VAP due to NF‐GNB were reported in <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a> (72%) and in <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> (64%). In contrast, <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> intended to enrol participants with early‐onset VAP (mechanical ventilation for more than 24 hours, but less than eight days), and there were no cases of VAP due to NF‐GNB or MRSA. Lastly, <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> sought to recruit patients with a low probability of pneumonia, as determined by a Clinical Pulmonary Infection Score (CPIS, a composite score based upon high or low temperature, leukocyte count, quality of tracheal secretion, oxygenation and presence of radiographic infiltrates) of less than seven at day one and day three; pathogens associated with an episode of HAP were incompletely reported. </p> <p>Antibiotics had been administered prior to the onset of VAP in 100% participants in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>, 84% of participants in <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>, and 68% of participants in <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>. Data regarding previous antibiotic use were not provided in <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a> nor in <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>, and prior antibiotic administration for pneumonia was an exclusion criterion in <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>. </p> <p>Where reported, duration of mechanical ventilation prior to onset of VAP differed between studies: 14 days (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>), 10 days (<a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>), nine days (<a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>), and three days (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>). This duration was not reported in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>, and in <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> 42% participants were not mechanically ventilated at enrolment. </p> <p>Presence of underlying respiratory disease was inadequately reported for comparison between studies, and for illness severity scores only limited comparison was possible; mean SAPS II (Simplified Acute Physiology Score II) scores were 45 for <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>, 43 for <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>, and 39 for <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; SOFA (Sequential Organ Failure Assessment) scores were mean 7.3 for <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> and 5.8 for <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>, and median 6 for <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>. </p> <p>Pneumonia definitions varied between studies. All included the need for radiological and clinical features; in several studies the diagnosis of primary episode of VAP necessitated a threshold quantitative culture of broncho‐alveolar lavage (BAL; <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>, the "MITT" cohort in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>) or protected specimen brush (PSB) samples (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>). In <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>, threshold quantitative culture was permissible from endotracheal aspirate (ETA) or PSB, and in <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>, quantitative culture was not required if the CPIS was above six, or blood or pleural cultures were positive. In contrast, for <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> an episode of HAP was defined according to the development of new infiltrates on chest radiography together with clinical suspicion, and microbiological confirmation was not required. </p> <p>CPIS was not reported by <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> or by <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>. However, CPIS was six or above in 92% participants in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> and 67% in <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>. In <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>, patients with CPIS above six were excluded from study, and mean CPIS was 4.9 on day of enrolment. </p> </section> <section id="CD007577-sec-0064"> <h5 class="title">Interventions</h5> <p>For the majority of studies, a short course of seven or eight days was compared with a prolonged course of 10 to 15 days. <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> and <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> allocated patients to receive either eight days or 15 days of antibiotic therapy, <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a> and <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> to seven days or 10 days of therapy, and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> to eight days or 12 days of therapy. <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> allocated patients whose CPIS remained less than seven on the third day of antibiotic therapy to receive either three days' antibiotic therapy or non‐fixed "standard course" therapy (typically 10 to 21 days at the start of the recruitment), as determined by the treating physician. </p> <p>The most common classes of antibiotics used in <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> were an aminoglycoside or quinolone plus beta‐lactam (91%); in <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>, beta‐lactams were used in 90% of cases and aminoglycosides in 27% overall. In <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>, all participants received a beta‐lactam for the allocated duration, combined with an aminoglycoside for the first five days of therapy. Carbapenems were used in 100% cases in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>, with doripenem in the short‐course group and imipenem in the prolonged‐therapy group. Antibiotic class data are not presented in <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>. In <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>, ciprofloxacin monotherapy was used in the short‐course group, but varied widely in the standard‐therapy group (including glycopeptide, beta‐lactam, aminoglycoside and macrolide therapy). </p> <p>Initial antibiotic therapy was appropriate (according to respiratory specimen culture and sensitivity results) in all cases in <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> and <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> (from which any patients initially treated with inappropriate antibiotics were subsequently excluded) and in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> (in which the pathogen's imipenem minimum inhibitory concentration, MIC, was confirmed as less than 8 μg/mL). In one case among each of the short‐course and prolonged‐therapy groups the initial antibiotic therapy was inappropriate in both <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a> and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>. Appropriateness of initial therapy is not described in <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>. </p> <p>Uniquely among the included studies, <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> allocated patients in the short‐course doripenem group to receive their antibiotic therapy as a theoretically favourable four‐hour infusion every eight hours (according to pharmacokinetic/pharmacodynamic models), whereas in the prolonged‐course group imipenem was administered as a one‐hour infusion eight‐hourly. </p> </section> <section id="CD007577-sec-0065"> <h5 class="title">Outcomes</h5> <p>Although some unambiguous outcome measures were reported in the included studies (mortality, length of stay, duration of mechanical ventilation), discussion is required regarding other measures, including 'clinical resolution', 'recurrence' and 'relapse'. </p> <p>The term 'clinical resolution' used in this review refers to the outcome measures described by <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> ('clinical cure', evaluated at day 21 according to clinical and radiographic criteria), <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> ('clinical cure', or resolution of clinical features and improvement or lack of progression of radiographic response to therapy, evaluated at day 10 of study) and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> ('clinical resolution', described as lessening of symptoms and signs of infection such that additional therapy is not required, evaluation day unspecified). </p> <p>'Recurrence' data were presented by <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>, <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>, <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>, and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>. In <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>, an episode of recurrence, whether relapse (i.e. due to same initial causative organism) or super‐infection (i.e. due to other organism), again required threshold quantitative culture of BAL or PSB; distal respiratory tract sampling could be prompted by changes in oxygenation or haemodynamic status, or development of fever, purulent secretions or new infiltrates on chest radiography. For <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>, a relapse was defined as culture of original organism in conjunction with clinical or radiological signs of pneumonia or worsening SOFA score. In <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>, episodes of recurrence ('réinfection') were described in terms of infection due to initial organism or other organism, presumably using the same clinical, radiographic and microbiological criteria as for a primary episode of VAP. <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> defined episodes of recurrence according to clinical and microbiological features occurring 72 hours or more after completing an initial course of antibiotic therapy. </p> </section> </section> <section id="CD007577-sec-0066"> <h4 class="title">Excluded studies</h4> <p>We excluded studies if they had been published as a full paper elsewhere (<a href="./references#CD007577-bbs2-0010" title="ChastreJ , WolffM , FagonJY , ChevretS . Comparison of two durations of antibiotic therapy to treat ventilator‐associated pneumonia (VAP). American Thoracic Society Meeting, Seattle, Washington. 2003:A015. ">Chastre 2003b</a>; <a href="./references#CD007577-bbs2-0026" title="SinghN . Short‐course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU. Annual Meeting of the Infectious Disease Society of America, Denver, Colorado. 1998. ">Singh 1998</a>; <a href="./references#CD007577-bbs2-0031" title="WolffM , ChastreJ , FagonJY , ChevretS . Comparison of two durations of antibiotic therapy for ventilator‐associated pneumonia (VAP) caused by non‐fermenting gram negative bacilli (NF‐GNB). American Thoracic Society Meeting Seattle, Washington. 2003:A860. ">Wolff 2003</a>), were not RCTs (<a href="./references#CD007577-bbs2-0013" title="IbrahimEH ,  WardS ,  ShermanG ,  SchaiffR ,  FraserVJ ,  KollefMH . Experience with a clinical guideline for the treatment of ventilator‐associated pneumonia. Critical Care Medicine2001;29(6):1109‐15. ">Ibrahim 2001</a>; <a href="./references#CD007577-bbs2-0016" title="KollefMH ,  KollefKE . Antibiotic utilization and outcomes for patients with clinically suspected ventilator‐associated pneumonia and negative quantitative BAL culture results. Chest2005;128:2706‐13. ">Kollef 2005</a>; <a href="./references#CD007577-bbs2-0023" title="RelloJ ,  VidaurL ,  SandiumengeA ,  RodríguezA ,  GualisB ,  BoqueC ,  etal . De‐escalation therapy in ventilator‐associated pneumonia. Critical Care Medicine2004;32(11):2183‐90. ">Rello 2004</a>), investigated a diagnostic strategy (<a href="./references#CD007577-bbs2-0009" title="Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator‐associated pneumonia. New England Journal of Medicine2006;355(25):2619‐30. ">CCCTG 2006</a>; <a href="./references#CD007577-bbs2-0011" title="FagonJY , ChastreJ , WolffM , GervaisC , Parer‐AubasS , StéphanF , et al. Invasive and noninvasive strategies for management of suspected ventilator‐associated pneumonia. A randomized trial. Annals of Internal Medicine2000;132(8):621‐30. ">Fagon 2000</a>; <a href="./references#CD007577-bbs2-0021" title="PeeryC , ChendrasekharA , MoormanDW , TimberlakeGA . Ventilator‐associated pneumonia therapy: protected specimen brushing versus tracheal aspirate data. Journal of Applied Research2001;1(2):1. ">Peery 2001</a>; <a href="./references#CD007577-bbs2-0024" title="Sanchez‐NietoJM , TorresA , Garcia‐CordobaF , El‐EbiaryM , CarrilloA , RuizJ , et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator‐associated pneumonia: a pilot study. American Journal of Respiratory and Critical Care Medicine1998;157(2):371‐6. ">Sanchez‐Nieto 1998</a>; <a href="./references#CD007577-bbs2-0027" title="SoleVJ , FernandezJA , BenitezAB , Cardenosa CendreroJA , Rodriguez deCF . Impact of quantitative invasive diagnostic techniques in the management and outcome of mechanically ventilated patients with suspected pneumonia. Critical Care Medicine2000;28(8):2737‐41. ">Sole 2000</a>), or used a de‐escalation or discontinuation clinical protocol (<a href="./references#CD007577-bbs2-0015" title="KimJW , ChungJ , ChoiSH , JangHJ , HongSB , LimCM , et al. Early use of imipenem/cilastatin and vancomycin followed by de‐escalation versus conventional antimicrobials without de‐escalation for patients with hospital‐acquired pneumonia in a medical ICU: a randomized clinical trial. Critical Care2012;16(1):R28. ">Kim 2012</a>; <a href="./references#CD007577-bbs2-0019" title="MicekST ,  WardS ,  FraserVJ ,  KollefMH . A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator‐associated pneumonia. Chest2004;125(5):1791‐9. ">Micek 2004</a>), or biomarker (<a href="./references#CD007577-bbs2-0007" title="BouadmaL , LuytCE , TubachF , CraccoC , AlvarezA , SchwebelC , et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet2010;375(9713):463‐74. ">Bouadma 2010</a>; <a href="./references#CD007577-bbs2-0019" title="MicekST ,  WardS ,  FraserVJ ,  KollefMH . A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator‐associated pneumonia. Chest2004;125(5):1791‐9. ">Micek 2004</a>; <a href="./references#CD007577-bbs2-0022" title="PontetJ , PacielD , OliveraW , BentancourtS , CancelaM , GervasJ . Procalcitonin (PCT) guided antibiotic treatment in ventilator associated pneumonia (VAP). Multi‐centre, clinical prospective, randomized‐controlled study. American Thoracic Society International Conference, San Francisco, California, USA. 2007:A76. ">Pontet 2007</a>; <a href="./references#CD007577-bbs2-0028" title="StolzD ,  SmyrniosN ,  EggimannP ,  ParggerH ,  ThakkarN ,  SiegemundM ,  etal . Procalcitonin for reduced antibiotic exposure in ventilator‐associated pneumonia: a randomised study. European Respiratory Journal2009;34(6):1364‐75. ">Stolz 2009a</a>), to guide duration of therapy rather than comparing fixed durations of therapy. We also excluded two studies published in abstract form: <a href="./references#CD007577-bbs2-0018" title="Maldonado‐OrtizEA , NiedermanMS , NaculF , RodríguezA , CeballosS , OsorioJ . How long is enough to treat ventilator associated pneumonia? A randomized pilot study: the Latinoamerican experience. Chest2004;126(Suppl 4):717. ">Maldonado‐Ortiz 2004</a> because of inadequate outcome data and perceived risk of bias, and <a href="./references#CD007577-bbs2-0017" title="LabelleAJ , SchoenbergN , SkrupkyL , KollefM . Five versus seven day antibiotic course for the treatment of pneumonia in the intensive care unit. American Journal of Respiratory and Critical Care Medicine. 2012; Vol. 185:A6078. ">Labelle 2012</a> because fixed courses of therapy appear not to have been utilised and duration of therapy was not significantly different between groups. </p> <p>Please refer to the <a href="./references#CD007577-sec-0116" title="">Characteristics of excluded studies</a> table. </p> </section> </section> <section id="CD007577-sec-0067"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias is presented in detail in the <a href="./references#CD007577-sec-0115" title="">Characteristics of included studies</a> table, presented graphically in <a href="#CD007577-fig-0001">Figure 1</a> and summarised in <a href="#CD007577-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD007577-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007577-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD007577-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007577-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD007577-sec-0068"> <h4 class="title">Allocation</h4> <p>Sequence generation was adequate in four studies (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>), and unclear in two studies (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0026" title="SinghN . Short‐course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU. Annual Meeting of the Infectious Disease Society of America, Denver, Colorado. 1998. ">Singh 1998</a>). Allocation concealment was adequate in three studies (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>), and unclear in three studies (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>). </p> </section> <section id="CD007577-sec-0069"> <h4 class="title">Blinding</h4> <p>In only one of the studies were there efforts to blind (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>). In one study it was unclear whether blinding had been used and contact with the authors has been unsuccessful (<a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>). Four studies were unblinded (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>; <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>). </p> </section> <section id="CD007577-sec-0070"> <h4 class="title">Incomplete outcome data</h4> <p>Incomplete outcome data reporting was adequate in four studies (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>; <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>), and unclear in two (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>). </p> </section> <section id="CD007577-sec-0071"> <h4 class="title">Selective reporting</h4> <p>Selective reporting appears to have been a feature of one study (<a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>), and was unclear in five (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>). </p> </section> <section id="CD007577-sec-0072"> <h4 class="title">Other potential sources of bias</h4> <p>Interpretation of <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> is made more difficult by there having been multiple interventions: the study compares a short course of one antibiotic administered according to theoretically favourable pharmacokinetic modelling versus a prolonged course of another antibiotic administered over a shorter, more conventional time course. Furthermore, the study was stopped early, having enrolled approximately half of the target (480) recruitment, on the basis of inferior efficacy and greater mortality in the short‐course therapy group. Lastly, data from five sites, which had enrolled 41 patients, were excluded from primary analysis because of poor compliance with agreed good clinical practice. </p> <p><a href="./references#CD007577-bbs2-0026" title="SinghN . Short‐course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU. Annual Meeting of the Infectious Disease Society of America, Denver, Colorado. 1998. ">Singh 1998</a> was stopped early by an institutional review board. Results for patients managed in the 'experimental' group appear to have influenced management of patients subsequently allocated to the 'standard therapy group'. </p> </section> </section> <section id="CD007577-sec-0073"> <h3 class="title" id="CD007577-sec-0073">Effects of interventions</h3> <p>See: <a href="./full#CD007577-tbl-0001"><b>Summary of findings for the main comparison</b> Should short‐course antibiotic therapy versus prolonged‐course antibiotic therapy be used in critically ill patients with hospital‐acquired pneumonia?</a> </p> <p>Outcomes are presented in detail (including forest plots) in the <a href="./references#CD007577-sec-0099" title="">Data and analyses</a> section below. Outcomes are summarised in <a href="./full#CD007577-tbl-0001">summary of findings Table for the main comparison</a> below. </p> <section id="CD007577-sec-0074"> <h4 class="title">Primary outcomes</h4> <section id="CD007577-sec-0075"> <h5 class="title">1. 28‐day mortality</h5> <p>Twenty‐eight‐day mortality was reported in three studies and did not differ significantly between short‐course and prolonged‐course therapy groups upon meta‐analysis (odds ratio (OR) 1.18; 95% confidence interval (CI) 0.77 to 1.80; <a href="./references#CD007577-fig-0003" title="">Analysis 1.1</a>); despite differences in study characteristics, heterogeneity appeared to be low (I<sup>2</sup> statistic = 0%) (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>). Twenty‐eight‐day mortality was reported as significantly greater in the small subgroup of patients in <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> with ventilator‐associated pneumonia (VAP) due to<i>P. aeruginosa</i> treated with short‐course therapy (6/17 (35.3%) versus 0/10 (0.0%); 95% CI 12.6% to 58.0%; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>). However, including data for patients with other non‐fermenting Gram‐negative bacilli (NF‐GNB) VAP (i.e. <i>Acinetobacter spp</i>.) from this study together with patients with NF‐GNB VAP from <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> in meta‐analysis, there was no significant difference in 28‐day mortality between short‐ and prolonged‐course therapy (<a href="./references#CD007577-fig-0003" title="">Analysis 1.1</a>). Similarly, we identified no differences in 28‐day mortality between intervention groups for patients with VAP due to MRSA, and between groups for patients with VAP not due to MRSA/NF‐GNB, or with an unspecified organism. </p> <p>We performed sensitivity analysis to exclude data from <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>, given concerns regarding multiple interventions, premature cessation and compliance of several centres with agreed good clinical practice, but this did not lead to significant differences in 28‐day mortality on meta‐analysis (<a href="./appendices#CD007577-sec-0105">Appendix 5</a>). </p> </section> <section id="CD007577-sec-0076"> <h5 class="title">2. Recurrence of pneumonia</h5> <p>Recurrence data were presented in four VAP studies (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>). Overall, there was a trend to increased recurrence following a short course of therapy (OR 1.41; 95% CI 0.94 to 2.12; <a href="./references#CD007577-fig-0004" title="">Analysis 1.2</a>; I<sup>2</sup> statistic = 5%, suggesting low heterogeneity) in treatment of VAP. However, meta‐analysis of the two studies reporting recurrence data specifically for patients with VAP due to NF‐GNB demonstrated significantly greater recurrence for VAP due to NF‐GNB in the short‐course group (OR 2.18; 95% CI 1.14 to 4.16; P value = 0.02; <a href="./references#CD007577-fig-0004" title="">Analysis 1.2</a>; I<sup>2</sup> statistic = 0%), though recurrence rate due to multi‐resistant organism was lower in the short‐course group in one study (OR 0.44; 95% CI 0.21 to 0.95; data from <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> only; <a href="./references#CD007577-fig-0013" title="">Analysis 1.11</a>). </p> <p>We performed a sensitivity analysis to exclude data from <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> (data currently published in abstract form only) and from <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> (early‐onset VAP). On exclusion of data from <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>, increased recurrence following short‐course therapy for VAP due to NF‐GNB was no longer statistically significant (<a href="./appendices#CD007577-sec-0105">Appendix 5</a>). </p> </section> <section id="CD007577-sec-0077"> <h5 class="title">3. 28‐day antibiotic‐free days</h5> <p><a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> and <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a> provided data on 28‐day antibiotic‐free days for patients with VAP (total number of antibiotic‐free days over the 28‐day period, which begins with onset of VAP and commencement of antibiotics). Antibiotic‐free days were significantly greater in the short‐course group (mean difference (MD) 4.02 days; 95% confidence interval (CI) 2.26 to 5.78; <a href="./references#CD007577-fig-0005" title="">Analysis 1.3</a>; I<sup>2</sup> statistic = 68%, indicating a high degree of heterogeneity) among patients with VAP due to all organisms (two studies), and in subgroups of patients with VAP due to NF‐GNB or MRSA (one study). </p> <p>With regards to other measures of antibiotic exposure, for HAP patients randomised to the short‐course therapy group in <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>, 28% of patients received antibiotics for more than three days, compared with 97% in the standard‐therapy group (P value = 0.0001). </p> </section> </section> <section id="CD007577-sec-0078"> <h4 class="title">Secondary outcomes</h4> <section id="CD007577-sec-0079"> <h5 class="title">1. Intensive care unit (ICU) mortality</h5> <p>We identified no significant differences between short‐ and prolonged‐course antibiotic therapy with respect to ICU mortality, reported in two studies (<a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>) (<a href="./references#CD007577-fig-0006" title="">Analysis 1.4</a>). </p> </section> <section id="CD007577-sec-0080"> <h5 class="title">2. In‐hospital mortality</h5> <p>We identified no significant differences between short‐ and prolonged‐course antibiotic therapy with respect to hospital mortality, reported in one study (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>) (<a href="./references#CD007577-fig-0007" title="">Analysis 1.5</a>). </p> <p>Other mortality outcomes were reported with respect to: 21 days (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-fig-0008" title="">Analysis 1.6</a>), 60 days (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-fig-0009" title="">Analysis 1.7</a>), and 90 days (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-fig-0010" title="">Analysis 1.8</a>). Again, we identified no significant differences between short‐ and prolonged‐course antibiotic therapy. </p> <p>We separately considered data from <a href="./references#CD007577-bbs2-0026" title="SinghN . Short‐course empiric antibiotic therapy for suspected nosocomial pneumonia: a proposed solution for indiscriminate antibiotic prescription for pulmonary infiltrates in the ICU. Annual Meeting of the Infectious Disease Society of America, Denver, Colorado. 1998. ">Singh 1998</a>, given the high proportion of non‐ventilated patients and the prerequisite that all included patients were at low risk of having pneumonia, according to Clinical Pulmonary Infection Score (CPIS). A trend towards lower 30‐day mortality was identified by the study authors in the short‐course group (OR 0.33; 95% CI 0.10 to 1.03). Outcomes for patients who were and were not mechanically ventilated were not reported separately. </p> </section> <section id="CD007577-sec-0081"> <h5 class="title">3. Clinical resolution of pneumonia</h5> <p>Clinical resolution outcomes were reported in three studies: <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> (evaluated at day 21), <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> (evaluated at day 10) and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> (unclear evaluation date). We observed a non‐significantly lower clinical resolution between treatment groups (OR 0.75; 95% CI 0.49 to 1.15; <a href="./references#CD007577-fig-0011" title="">Analysis 1.9</a>; I<sup>2</sup> statistic = 0%) for all patients, and for the small subgroup patients with VAP due to NF‐GNB reported in one study (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>). The authors of this last study also noted a significantly lower CPIS on day 11 among the prolonged‐therapy group compared with the short‐course group. </p> </section> <section id="CD007577-sec-0082"> <h5 class="title">4. Relapse of pneumonia</h5> <p>Relapse of pneumonia was non‐significantly higher following short‐course therapy for VAP among patients as a whole (OR 1.70; 95% CI 0.97 to 2.97; <a href="./references#CD007577-fig-0012" title="">Analysis 1.10</a>) and the subgroup with NF‐GNB (OR 2.08; 95% CI 0.92 to 4.70) in two studies (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>). </p> </section> <section id="CD007577-sec-0083"> <h5 class="title">5. Subsequent infection due to 'resistant organisms'</h5> <p>Recurrence rate due to multi‐resistant organisms was lower in the short‐course group in one study (OR 0.44; 95% CI 0.21 to 0.95; data from <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a> only; <a href="./references#CD007577-fig-0013" title="">Analysis 1.11</a>). </p> <p><a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> reported a composite measure of antibiotic resistance and/or superinfection following treatment of HAP; in the short‐course group, this adverse outcome rate was found to be significantly lower at 13% versus 33% (P value = 0.03; <a href="./references#CD007577-fig-0018" title="">Analysis 2.2</a>). </p> </section> <section id="CD007577-sec-0084"> <h5 class="title">6. Duration of ICU stay</h5> <p>Duration of ICU stay did not differ significantly between patients with VAP treated according to short‐course and prolonged‐course therapy (<a href="./references#CD007577-fig-0014" title="">Analysis 1.12</a>). </p> <p><a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> reported a significantly reduced mean length of ICU stay in the short‐course therapy group (9.4 versus 14.7 days; standard deviation (SD) data not presented; P value = 0.04). </p> </section> <section id="CD007577-sec-0085"> <h5 class="title">7. Duration of hospital stay</h5> <p>Duration of hospital stay did not differ significantly between patients with VAP treated according to short‐course and prolonged‐course therapy (<a href="./references#CD007577-fig-0015" title="">Analysis 1.13</a>). </p> </section> <section id="CD007577-sec-0086"> <h5 class="title">8. Duration of mechanical ventilation</h5> <p>Duration of mechanical ventilation did not differ significantly between patients with VAP treated according to short‐course and prolonged‐course therapy (<a href="./references#CD007577-fig-0016" title="">Analysis 1.14</a>). </p> </section> <section id="CD007577-sec-0087"> <h5 class="title">9. Mechanical ventilation‐free days</h5> <p>28‐day mechanical ventilation‐free days were reported in two studies, and did not differ significantly between study groups: mean 8.7 days (SD 9.1) in the short‐course and 9.1 days (SD 9.4) in the prolonged‐therapy group (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>), and 3.4 (SD 1.9) days in the short‐course versus 2.1 (SD 1.8) days in the prolonged‐therapy group (<a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>). </p> </section> <section id="CD007577-sec-0088"> <h5 class="title">10. Mortality attributable to HAP</h5> <p>The included trials did not report this outcome.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007577-sec-0089" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007577-sec-0089">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007577-sec-0147">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007577-sec-0089"></div> <section id="CD007577-sec-0090"> <h3 class="title" id="CD007577-sec-0090">Summary of main results</h3> <p>We identified six studies, which had enrolled a total of 1088 participants with pneumonia (92% of whom had ventilator‐associated pneumonia (VAP)) defined according to diverse radiological, clinical and microbiological criteria. There were notable differences in patient characteristics and interventions between studies, though for the most part this was not reflected in statistical heterogeneity. </p> <p>Considering the five studies that compared fixed durations of antibiotic therapy for VAP (seven to eight days versus 10 to 15 days), a shorter course of therapy was associated with significantly reduced antibiotic exposure in terms of 28‐day antibiotic‐free days in two studies (mean difference (MD) 4.02 days; 95% confidence interval (CI) 2.26 to 5.78), without any significant increase in mortality, duration of mechanical ventilation or duration of hospital stay, and irrespective of pathogen (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>). One study reported that a shorter course of antibiotic therapy was associated with a significant reduction in VAP recurrence due to multi‐resistant organisms (odds ratio (OR) 0.44; 95% CI 0.21 to 0.95) (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>). </p> <p>Clinical resolution of VAP was non‐significantly lower (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>) (OR 0.75; 95% CI 0.49 to 1.15) and recurrence was non‐significantly greater (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>; <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0003" title="Fekih HassenM , AyedS , Ben Sik AliH , GharbiR , MarghliS , ElatrousS . Duration of antibiotic therapy for ventilator‐associated pneumonia: comparison of 7 and 10 days. A pilot study. Annales Françaises d'Anesthésie et de Réanimation2009;28(1):16‐23. ">Fekih Hassen 2009</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>) (OR 1.41; 95% CI 0.94 to 2.12) for patients treated with a short course of therapy. A significant increase in recurrence was observed in the subgroup of patients with VAP due to non‐fermenting Gram‐negative bacilli (NF‐GNB) (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>) (OR 2.18; 95% CI 1.14 to 4.16), though not for those with VAP due to methicillin‐resistant <i>Staphylococcus aureus</i> (MRSA). Despite this, short‐course therapy for VAP due to NF‐GNB was not associated with other significantly poorer outcomes, in terms of mortality, mechanical ventilation‐free days and length of stay (<a href="./full#CD007577-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>For critically ill patients with suspected HAP (whether mechanically ventilated or not) but a low probability of pneumonia (according to a day one and day three Clinical Pulmonary Infection Score (CPIS) below seven; <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>), discontinuing antibiotic therapy at day three was associated with significantly shorter duration of antibiotic therapy (mean three days versus 9.8 days; P value = 0.0001 reported), a significantly reduced composite rate of superinfection and antimicrobial resistance (OR 0.29; 95% CI 0.09 to 0.92) and a significantly reduced duration of intensive care unit (ICU) stay. </p> </section> <section id="CD007577-sec-0091"> <h3 class="title" id="CD007577-sec-0091">Overall completeness and applicability of evidence</h3> <p>In this review, we have included only those studies using fixed durations of antibiotic therapy for hospital‐acquired pneumonia (HAP) in the critically ill; thus (unlike the previous version of our review), we have excluded studies that evaluated clinical response (e.g. <a href="./references#CD007577-bbs2-0019" title="MicekST ,  WardS ,  FraserVJ ,  KollefMH . A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator‐associated pneumonia. Chest2004;125(5):1791‐9. ">Micek 2004</a>) or a biomarker (procalcitonin; e.g. <a href="./references#CD007577-bbs2-0028" title="StolzD ,  SmyrniosN ,  EggimannP ,  ParggerH ,  ThakkarN ,  SiegemundM ,  etal . Procalcitonin for reduced antibiotic exposure in ventilator‐associated pneumonia: a randomised study. European Respiratory Journal2009;34(6):1364‐75. ">Stolz 2009a</a>) as a guide to variable courses of antibiotic therapy. The included studies enrolled 1088 medical and surgical (including cardio‐thoracic and neuro‐surgical) critically ill adults with HAP from ICUs in Africa, Asia, Europe, and North, Central and South America. However, studies were few in number, and participants, interventions and reported outcomes varied considerably. Furthermore, we identified only one study presenting outcome data for patients with HAP who were not receiving mechanical ventilation; separate outcome data are not presented for those subgroups of patients who were and were not receiving mechanical ventilation, and indeed all of the enrolled patients were required to have 'low probability' of pneumonia according to CPIS (<a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>). All other included studies focused entirely on patients with VAP. This limitation is important since there may be differences in patient characteristics and in bacterial aetiology between ICU cases of nosocomial pneumonia acquired in the presence or absence of assisted mechanical ventilation (<a href="./references#CD007577-bbs2-0054" title="EsperattiM , FerrerM , TheessenA , LiapikouA , ValenciaM , SaucedoL , et al. Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. American Journal of Respiratory and Critical Care Medicine2010;182:1533‐9. ">Esperatti 2010</a>; <a href="./references#CD007577-bbs2-0065" title="KohlenbergA , SchwabF , BehnkeM , GeffersC , GastmeierP . Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Medicine2010;36(6):971‐8. ">Kohlenberg 2010</a>); therefore, guidance that attempts to extrapolate from studies of patients with VAP to non‐ventilated patients with HAP may potentially be flawed. </p> <p>For critically ill patients (not necessarily requiring mechanical ventilation) with new radiographic infiltrates and a suspicion but low probability of pneumonia (for example, according to CPIS on day of diagnosis and 72 hours later), a short course (three days) of appropriate antibiotic therapy appears to be more suitable than a prolonged (10‐ to 21‐day) course (<a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>), though the generalisability of empiric ciprofloxacin monotherapy may be debated. Current American (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>), British (<a href="./references#CD007577-bbs2-0041" title="MastertonRG ,  GallowayA ,  FrenchG ,  StreetM ,  ArmstrongJ ,  BrownE ,  etal . Guidelines for the management of hospital‐acquired pneumonia in the UK: report of the working party on hospital‐acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy2008;62(1):5‐34. ">BSAC 2008</a>), and Canadian (<a href="./references#CD007577-bbs2-0083" title="RotsteinC , EvansG , BornA , GrossmanR , LightRB , MagderS , et al. Clinical practice guidelines for hospital‐acquired pneumonia and ventilator‐associated pneumonia in adults. Canadian Journal of Infectious Diseases and Medical Microbiology2008;19(1):19‐53. ">Rotstein 2008</a>) guidelines do not make any specific recommendations for this particular scenario. </p> <p>A fixed seven‐ to eight‐day course (rather than a 10‐ to 15‐day course) of antibiotic therapy appears to reduce overall antibiotic exposure and, on the basis of one study, to reduce the risk of further infection associated with resistant organisms. However, pooled data from two studies enrolling a total of 176 patients with VAP due to NF‐GNB, indicated that a fixed, short course of antibiotic therapy (seven or eight days) was associated with significantly increased risk of recurrence compared with a more prolonged course (12 or 15 days) (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>). Outcome data for a subgroup of patients with VAP due to NF‐GNB were presented in only one other study; a trend to lower clinical resolution following short‐course therapy was seen among patients with and without VAP due to NF‐GNB, and a higher CPIS was observed at day 10 after short‐course therapy (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>). </p> <p>Given the (non‐significantly) lower clinical resolution among patients treated with short‐course therapy and significantly higher recurrence among patients with VAP due to NF‐GNB, data regarding the continued presence of bacterial pathogens (e.g. <i>Pseudomonas sp.</i>) in respiratory specimens during and after fixed‐duration therapy may also have been of interest but were not routinely reported in the included studies. </p> <p>Diagnostic criteria for defining an episode of pneumonia were not uniform, and no study reported using the new Centers for Disease Control and Prevention (CDC) classification of ventilator‐associated events, including possible VAP (PVAP). </p> <p>Unfortunately, insufficient outcome data were available to allow exploration of other subgroups of interest, for example: presence of chronic respiratory illness, illness severity, prior administration of antibiotic therapy, prior duration of mechanical ventilation (i.e. early‐ or late‐onset VAP) and class of antibiotic (including combination therapy). Durations of therapy incorporating more novel modes of administration of potential interest were confounded by multiple interventions (e.g. extended infusion versus standard infusion, doripenem versus imipenem, short course versus prolonged course) or did not meet the inclusion criteria for this review (e.g. use of nebulised antibiotics, such as <a href="./references#CD007577-bbs2-0078" title="NiedermanMS , ChastreJ , CorkeryK , FinkJB , LuytCE , GarcíaMS . BAY41‐6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram‐negative pneumonia. Intensive Care Medicine2012;38:263‐71. ">Niederman 2012</a>). </p> <p>Subsequent infection due to resistant organisms was reported in only two studies (one of which reported as a composite measure only). Emergence of extra‐pulmonary infection, in particular, <i>C. difficile</i>‐associated disease, was surprisingly not reported at all. </p> <p>Both American (<a href="./references#CD007577-bbs2-0036" title="American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital‐acquired, ventilator‐associated, and healthcare‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2005;171(4):388‐416. ">ATS/IDSA 2005</a>) and British (<a href="./references#CD007577-bbs2-0041" title="MastertonRG ,  GallowayA ,  FrenchG ,  StreetM ,  ArmstrongJ ,  BrownE ,  etal . Guidelines for the management of hospital‐acquired pneumonia in the UK: report of the working party on hospital‐acquired pneumonia of the British Society for Antimicrobial Chemotherapy. Journal of Antimicrobial Chemotherapy2008;62(1):5‐34. ">BSAC 2008</a>) guidelines recommend that efforts should be made to shorten antibiotic therapy for HAP (including patients with VAP) to a duration of seven to eight days, where there has been clinical response and, in the case of American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) guidelines, where the causative organism is not <i>P. aeruginosa</i>. Overall, our review was broadly consistent with these guidelines; nevertheless, in the context of VAP due to NF‐GNB, short‐course therapy is unlikely to be appropriate for all patients and the optimal duration remains uncertain. </p> </section> <section id="CD007577-sec-0092"> <h3 class="title" id="CD007577-sec-0092">Quality of the evidence</h3> <p>Differences in participants, interventions and reported outcomes between studies meant that the number of studies contributing to a particular summary statistic was very small. We considered selection bias to be at low risk in three of the six included studies. Blinding occurred in only one of the six studies. We felt that there was significant other bias in two of the studies, because of multiple differences between intervention groups (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>), and because of contamination of the control group with early termination of the study (<a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a>). We therefore assessed the quality of evidence according to the GRADE classification as low to moderate for the main outcome measures (<a href="./full#CD007577-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD007577-sec-0093"> <h3 class="title" id="CD007577-sec-0093">Potential biases in the review process</h3> <p>We attempted to minimise bias in a number of ways. Our search strategy utilised the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE. In addition, we searched review articles and the 'grey literature' to minimise reporting bias. We established inclusion criteria prior to conduct of searches and, where necessary, we contacted trial authors to clarify study eligibility. We collected data using a standardised data collection form; when not available, we contacted trial authors to provide additional relevant data. We systematically assessed internal validity using the Cochrane 'Risk of bias' tool. </p> <p>The potential for study heterogeneity was evident at the planning stage of this review, for example, in terms of methodology, diagnostic criteria, illness severity and antibiotic class. We identified relevant subgroups a priori. However, outcome data were typically not presented in sufficient detail to enable adequate subgroup analysis (e.g. according to prior administration of antibiotic therapy, prior duration of mechanical ventilation, classes of antibiotic including combination therapy) and given methodological differences we used a random‐effects model for meta‐analysis. </p> <p>With a very small number of included studies, we were able to meta‐analyse data from a maximum of four (and more frequently only two or three) studies per outcome. We included studies that focused on early‐onset VAP (<a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a>), and those that primarily recruited patients with later‐onset VAP (e.g. <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>; <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>), with the intention of analysing according causative organism (e.g. NF‐GNB). We felt that this approach was appropriate, particularly given that the relationship between early‐ versus late‐onset VAP and the likelihood of pneumonia being due to a resistant organism has been questioned in recent reports (<a href="./references#CD007577-bbs2-0056" title="GastmeierP , SohrD , GeffersC , RüdenH , VonbergR , WelteT . Early‐ and late‐onset pneumonia: is this still a useful classification?. Antimicrobial Agents and Chemotherapy2009;53:2714‐8. ">Gastmeier 2009</a>; <a href="./references#CD007577-bbs2-0073" title="Martin‐LoechesI , TorresA , RinaudoM , TerraneoS , deRosaF , RamirezP , et al. Resistance patterns and outcomes in intensive care unit (ICU)‐acquired pneumonia. Validation of European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC) classification of multidrug resistant organisms. Journal of Infection2015;70:213‐22. ">Martin‐Loeches 2015</a>; <a href="./references#CD007577-bbs2-0080" title="RestrepoM , PetersonJ , FernandezJ , QinZ , FisherA , NicholsonS . Comparison of the bacterial etiology of early‐onset and late‐onset ventilator‐associated pneumonia in subjects enrolled in 2 large clinical studies. Respiratory Care2013;58:1220‐5. ">Restrepo 2013</a>). </p> <p>Due to marked differences in participants, interventions and reported outcomes between <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> and other studies, we considered outcomes for that study separately. </p> <p>We performed sensitivity analysis to exclude the results of <a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a> from 28‐day mortality data, which did not produce different findings. We also performed sensitivity analysis to exclude <a href="./references#CD007577-bbs2-0001" title="CapellierG , MocklyH , CharpentierC , AnnaneD , BlascoG , DesmettreT , et al. Early‐onset ventilator‐associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PloS One2012;7(8):e41290. ">Capellier 2012</a> (given its focus on early onset VAP) and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> (since it has been published only in abstract form) from the recurrence results, which led to recurrence among the subgroup of patients with VAP due to NF‐GNB no longer being statistically significant. </p> </section> <section id="CD007577-sec-0094"> <h3 class="title" id="CD007577-sec-0094">Agreements and disagreements with other studies or reviews</h3> <p>Three systematic reviews specifically focusing on duration of antibiotic therapy for VAP have been published (<a href="./references#CD007577-bbs2-0050" title="DimopoulosG , PoulakouG , PneumatikosIA , ArmaganidisA , KollefMH , MatthaiouDK . Short‐ versus long‐duration antibiotic regimens for ventilator‐associated pneumonia: a systematic review and meta‐analysis. Chest2013;144:1759‐67. ">Dimopoulos 2013</a>; <a href="./references#CD007577-bbs2-0052" title="DuganHA , MacLarenR , JungR . Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units. Journal of Clinical Pharmacy and Therapeutics2003;28(2):123‐9. ">Dugan 2003</a>; <a href="./references#CD007577-bbs2-0057" title="GrammatikosAP , SiemposII , MichalopoulosA , FalagasME . Optimal duration of the antimicrobial treatment of ventilator‐acquired pneumonia. Expert Review of Anti‐infective Therapy2008;6(6):861‐6. ">Grammatikos 2008</a>). The two earlier of these reviews included observational studies and studies focused on diagnostic strategies (for example, invasive versus noninvasive diagnosis of VAP, <a href="./references#CD007577-bbs2-0011" title="FagonJY , ChastreJ , WolffM , GervaisC , Parer‐AubasS , StéphanF , et al. Invasive and noninvasive strategies for management of suspected ventilator‐associated pneumonia. A randomized trial. Annals of Internal Medicine2000;132(8):621‐30. ">Fagon 2000</a>). Notably, the <a href="./references#CD007577-bbs2-0052" title="DuganHA , MacLarenR , JungR . Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units. Journal of Clinical Pharmacy and Therapeutics2003;28(2):123‐9. ">Dugan 2003</a> review also appears to have been written before publication of the Pneuma study, the largest randomised controlled trial (RCT) to date to investigate duration of therapy for VAP (<a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>). The most recently published systematic review, <a href="./references#CD007577-bbs2-0050" title="DimopoulosG , PoulakouG , PneumatikosIA , ArmaganidisA , KollefMH , MatthaiouDK . Short‐ versus long‐duration antibiotic regimens for ventilator‐associated pneumonia: a systematic review and meta‐analysis. Chest2013;144:1759‐67. ">Dimopoulos 2013</a>, restricted itself to RCTs as did we, but excluded <a href="./references#CD007577-bbs2-0006" title="SinghN , RogersP , AtwoodCW , WagenerMM , YuVL . Short‐course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine2000;162:505‐11. ">Singh 2000</a> (presumably on the basis that it included non‐ventilated patients and all patients had a low probability of pneumonia) and <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a> (since it is currently published in abstract form only). In their review, relapse was chosen as a primary outcome measure rather than recurrence. </p> <p>The conclusions of <a href="./references#CD007577-bbs2-0057" title="GrammatikosAP , SiemposII , MichalopoulosA , FalagasME . Optimal duration of the antimicrobial treatment of ventilator‐acquired pneumonia. Expert Review of Anti‐infective Therapy2008;6(6):861‐6. ">Grammatikos 2008</a>, namely that short‐course antibiotic therapy for VAP not caused by NF‐GNB does not appear to adversely affect mortality, recurrence or length of stay (<a href="./references#CD007577-bbs2-0057" title="GrammatikosAP , SiemposII , MichalopoulosA , FalagasME . Optimal duration of the antimicrobial treatment of ventilator‐acquired pneumonia. Expert Review of Anti‐infective Therapy2008;6(6):861‐6. ">Grammatikos 2008</a>), are consistent with the findings from our review and those of <a href="./references#CD007577-bbs2-0050" title="DimopoulosG , PoulakouG , PneumatikosIA , ArmaganidisA , KollefMH , MatthaiouDK . Short‐ versus long‐duration antibiotic regimens for ventilator‐associated pneumonia: a systematic review and meta‐analysis. Chest2013;144:1759‐67. ">Dimopoulos 2013</a>. <a href="./references#CD007577-bbs2-0052" title="DuganHA , MacLarenR , JungR . Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units. Journal of Clinical Pharmacy and Therapeutics2003;28(2):123‐9. ">Dugan 2003</a> concluded that shorter‐course therapy may be associated with reduced antimicrobial resistance, which is consistent with <a href="./references#CD007577-bbs2-0002" title="ChastreJ , WolffM , FagonJY , ChevretS , ThomasF , WermertD , et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator‐associated pneumonia in adults: a randomized trial. JAMA2003;290(19):2588‐98. ">Chastre 2003a</a>. However, studies published subsequent to their review have been less supportive of the benefits of short‐course therapy in reducing ICU and hospital length of stay. Having excluded <a href="./references#CD007577-bbs2-0005" title="MedinaJC , Perez ProttoSE , PacielD , PontetJ , SaldunP , BerroM . Antibiotic treatment for the ventilator‐associated pneumonia: 8 vs. 12 days randomized trial preliminary data. Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL. 2007. ">Medina 2007</a>, the systematic review published by <a href="./references#CD007577-bbs2-0050" title="DimopoulosG , PoulakouG , PneumatikosIA , ArmaganidisA , KollefMH , MatthaiouDK . Short‐ versus long‐duration antibiotic regimens for ventilator‐associated pneumonia: a systematic review and meta‐analysis. Chest2013;144:1759‐67. ">Dimopoulos 2013</a> reported a non‐significantly greater relapse in patients with VAP due to NF‐GNB treated with short‐course therapy, rather than the significantly greater recurrence that we found upon meta‐analysis. </p> <p>Our finding that short‐course antibiotic therapy for VAP in the absence of NF‐GNB may be adequate, without increased risk of recurrence or mortality, is consistent with data from observational studies. <a href="./references#CD007577-bbs2-0049" title="DennesenPJ , van derVenAJ , KesselsAG , RamsayG , BontenMJ . Resolution of infectious parameters after antimicrobial therapy in patients with ventilator‐associated pneumonia. American Journal of Respiratory and Critical Care Medicine2001;163(6):1371‐5. ">Dennesen 2001</a> demonstrated in 27 cases of VAP treated with appropriate initial antimicrobial therapy that clinical resolution occurred within the first six days of treatment and that <i>S. pneumoniae</i> , <i>H. influenzae</i> and <i>S. aureus</i> were eradicated within this period. In contrast, in Dennesen's study <i>P. aeruginosa</i> was isolated from endotracheal aspirates in all patients 15 days after the initiation of therapy, despite a mean 12.7 days of antibiotic treatment. Similarly, after seven days' appropriate antibiotic therapy for VAP, <a href="./references#CD007577-bbs2-0053" title="ElSolhAA , ChoiG , SchultzMJ , PinedaLA , MankowskiC . Clinical and hemostatic responses to treatment in ventilator‐associated pneumonia: role of bacterial pathogens. Critical Care Medicine2007;35(2):490‐6. ">El Solh 2007</a> observed a disparity between clinical response and persistent respiratory colonisation, with <i>P. aeruginosa</i> continuing to be cultured from broncho‐alveolar lavage (BAL) despite improvements in CPIS. This persistence may be clinically significant. <a href="./references#CD007577-bbs2-0096" title="ZhuoH , YangK , LynchSV , DotsonRH , GliddenDV , SinghG , et al. Increased mortality of ventilated patients with endotracheal Pseudomonas aeruginosa without clinical signs of infection. Critical Care Medicine2008;36(9):2495‐503. ">Zhuo 2008</a> demonstrated that the bacterial load in mechanically ventilated patients colonised with <i>P. aeruginosa</i> but without meeting the clinical criteria for VAP may predict outcome; in their study, high <i>P. aeruginosa</i> load was associated with a significantly greater 28‐day mortality. </p> <p>A reliable measure of clinical or microbiological response to treatment has appeal as a means of identifying those for whom a shorter course of therapy may be appropriate, particularly among those with VAP due to NF‐GNB. Kollef observed 10 days after initiation of antibiotic therapy for VAP due to Gram‐negative bacteria, that CPIS was lower among patients treated for 10 days rather than seven days (<a href="./references#CD007577-bbs2-0004" title="KollefM , ChastreJ , RestrepoM , MichielsB , KanigaK , CirilloI , et al. A randomized trial of 7‐day doripenem versus 10‐day imipenem‐cilastatin for ventilator‐associated pneumonia. Critical Care2012;16:R218. ">Kollef 2012</a>). In a non‐randomised study, use of repeat BAL to guide duration of therapy for VAP in surgical/trauma patients led to a reduction in duration of therapy among patients with VAP due to NF‐GNB compared with a control group (mean 10.7 versus 14.4 days respectively) without there being any overall increase in ventilator‐free ICU days, in‐hospital mortality and VAP relapse (<a href="./references#CD007577-bbs2-0076" title="MuellerEW ,  CroceMA ,  BoucherBA ,  HanesSD ,  WoodGC ,  SwansonJM ,  etal . Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator‐associated pneumonia. Journal of Trauma2007;63(6):1329‐37. ">Mueller 2007</a>). <a href="./references#CD007577-bbs2-0007" title="BouadmaL , LuytCE , TubachF , CraccoC , AlvarezA , SchwebelC , et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet2010;375(9713):463‐74. ">Bouadma 2010</a>, <a href="./references#CD007577-bbs2-0022" title="PontetJ , PacielD , OliveraW , BentancourtS , CancelaM , GervasJ . Procalcitonin (PCT) guided antibiotic treatment in ventilator associated pneumonia (VAP). Multi‐centre, clinical prospective, randomized‐controlled study. American Thoracic Society International Conference, San Francisco, California, USA. 2007:A76. ">Pontet 2007</a>, and <a href="./references#CD007577-bbs2-0028" title="StolzD ,  SmyrniosN ,  EggimannP ,  ParggerH ,  ThakkarN ,  SiegemundM ,  etal . Procalcitonin for reduced antibiotic exposure in ventilator‐associated pneumonia: a randomised study. European Respiratory Journal2009;34(6):1364‐75. ">Stolz 2009a</a> reported reductions in antibiotic exposure in patients with VAP treated according to a procalcitonin‐guided algorithm compared with standard treatment in RCTs, without observing an increase in mortality. Recurrence rates did not differ between groups in one of these studies (<a href="./references#CD007577-bbs2-0022" title="PontetJ , PacielD , OliveraW , BentancourtS , CancelaM , GervasJ . Procalcitonin (PCT) guided antibiotic treatment in ventilator associated pneumonia (VAP). Multi‐centre, clinical prospective, randomized‐controlled study. American Thoracic Society International Conference, San Francisco, California, USA. 2007:A76. ">Pontet 2007</a>), though outcomes for patients specifically with NF‐GNB VAP were not reported at all. </p> <p>To summarise, there are very few data for non‐ventilated patients with HAP. For patients with VAP, although short‐course (seven to eight days) therapy for VAP generally appears to be safe, the increased rate of recurrence of VAP due to NF‐GNB among patients administered a fixed, short course of antibiotic therapy demonstrated in our review may reflect inadequate microbiological and/or clinical response to treatment. It would therefore appear that further work is warranted to establish the optimal duration of therapy particularly for these patients, perhaps involving strategies that enable individualisation of treatment. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007577-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007577-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007577-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 1 28‐day mortality." data-id="CD007577-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 1 28‐day mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 2 Recurrence of pneumonia." data-id="CD007577-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 2 Recurrence of pneumonia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 3 28‐day antibiotic‐free days." data-id="CD007577-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 3 28‐day antibiotic‐free days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 4 ITU mortality." data-id="CD007577-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 4 ITU mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 5 In‐hospital mortality." data-id="CD007577-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 5 In‐hospital mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 6 21‐day mortality." data-id="CD007577-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 6 21‐day mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 7 60‐day mortality." data-id="CD007577-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 7 60‐day mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 8 90‐day mortality." data-id="CD007577-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 8 90‐day mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 9 Clinical resolution." data-id="CD007577-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 9 Clinical resolution. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 10 Relapse of pneumonia." data-id="CD007577-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 10 Relapse of pneumonia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 11 Subsequent infection due to resistant organism." data-id="CD007577-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 11 Subsequent infection due to resistant organism. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 12 Duration of ICU stay." data-id="CD007577-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 12 Duration of ICU stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 13 Duration of hospital stay." data-id="CD007577-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 13 Duration of hospital stay. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-001-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-001-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 14 Duration of mechanical ventilation." data-id="CD007577-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP, Outcome 14 Duration of mechanical ventilation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-001-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Discontinuation of antibiotics according to Clinical Pulmonary Infection Score, Outcome 1 30‐day mortality." data-id="CD007577-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Discontinuation of antibiotics according to Clinical Pulmonary Infection Score, Outcome 1 30‐day mortality. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007577-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/urn:x-wiley:14651858:media:CD007577:CD007577-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_t/tCD007577-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Discontinuation of antibiotics according to Clinical Pulmonary Infection Score, Outcome 2 Episodes of superinfection or antimicrobial resistance." data-id="CD007577-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Discontinuation of antibiotics according to Clinical Pulmonary Infection Score, Outcome 2 Episodes of superinfection or antimicrobial resistance. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/media/CDSR/CD007577/image_n/nCD007577-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007577-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Should short‐course antibiotic therapy versus prolonged‐course antibiotic therapy be used in critically ill patients with hospital‐acquired pneumonia?</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Should short‐course antibiotic therapy versus prolonged‐course antibiotic therapy be used in critically ill patients with hospital‐acquired pneumonia? </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> hospital‐acquired pneumonia<br/> <b>Settings:</b> intensive care<br/> <b>Intervention:</b> short‐course antibiotic therapy<br/> <b>Comparison:</b> prolonged‐course antibiotic therapy </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Prolonged‐course antibiotic therapy</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Short‐course antibiotic therapy</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>175 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>201 per 1000</b> <br/> (141 to 277) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.18</b> <br/> (0.77 to 1.8) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>598<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality NF‐GNB</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>265 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>255 per 1000</b> <br/> (123 to 450) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 0.95</b> <br/> (0.39 to 2.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>179<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mortality MRSA</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>238 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>286 per 1000</b> <br/> (91 to 614) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.28</b> <br/> (0.32 to 5.09) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence of pneumonia</b> <br/> Clinical and/or microbiological criteria </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>180 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>237 per 1000</b> <br/> (171 to 318) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.41</b> <br/> (0.94 to 2.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>733<br/> (19 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence of pneumonia NF‐GNB</b> <br/> Clinical and/or microbiological criteria </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>247 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>417 per 1000</b> <br/> (272 to 577) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 2.18</b> <br/> (1.14 to 4.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Recurrence of pneumonia MRSA</b> <br/> Clinical and/or microbiological criteria </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>370 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>479 per 1000</b> <br/> (66 to 920) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>OR 1.56</b> <br/> (0.12 to 19.61) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>28‐day antibiotic‐free days</b> <br/> Follow‐up: 28 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>The mean 28‐day antibiotic free days in the intervention groups was<br/> <b>4.02 higher</b> <br/> (2.26 to 5.78 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>431<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>MRSA:</b> methicillin‐resistant <i>Staphylococcus aureus</i>; <b>NF‐GNB:</b> non‐fermenting Gram‐negative bacilli; <b>OR:</b> odds ratio </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Low total number of events.<br/> <sup>2</sup>Kollef et al. Multiple interventions (short versus prolonged duration, doripenem versus imipenem, extended versus standard infusion), protocol violations at several centres and premature cessation of study.<br/> <sup>3</sup>Differences in duration of mechanical ventilation prior to episode of pneumonia and differences in bacterial aetiology.<br/> <sup>4</sup>Presumed differences in administration of antibiotics (outside of context of study) between studies. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Should short‐course antibiotic therapy versus prolonged‐course antibiotic therapy be used in critically ill patients with hospital‐acquired pneumonia?</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/full#CD007577-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007577-tbl-0002"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 28‐day mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>598</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.77, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>179</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.39, 2.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [0.32, 5.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Non NF‐GNB/MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [0.73, 3.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Unspecified organism</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.53, 2.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence of pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>733</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.94, 2.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.18 [1.14, 4.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.56 [0.12, 19.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Non NF‐GNB/MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>478</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.64, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 Unspecified organism</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.14, 9.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 28‐day antibiotic‐free days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.02 [2.26, 5.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.5 [2.25, 6.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.0 [4.14, 11.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Non NF‐GNB/ MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.70 [2.09, 5.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Unspecified organism</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.3 [1.03, 3.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 ITU mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.37, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 In‐hospital mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.71, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.36, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.47 [0.43, 4.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Non NF‐GNB/MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.72, 2.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 21‐day mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.41, 2.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 60‐day mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>401</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.55, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.35, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.29, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Non NF‐GNB/ MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.49, 1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 90‐day mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.49, 1.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Clinical resolution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.49, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.16, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 Unspecified organism</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>417</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.51, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Relapse of pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>626</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [0.97, 2.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.08 [0.92, 4.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.14, 3.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 Non NF‐GNB/MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.41 [0.51, 3.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 Unspecified organism</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>225</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.92 [0.58, 14.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Subsequent infection due to resistant organism <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.44 [0.21, 0.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Duration of ICU stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>656</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [1.00, 1.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 NF‐GNB</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>127</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐5.40, 7.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.90 [‐8.39, 14.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Non NF‐GNB/MRSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.45 [‐1.02, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 Unspecified organism</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.60 [‐4.61, 1.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Duration of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐4.11, 2.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Duration of mechanical ventilation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.51, 0.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Short (fixed)‐course antibiotic therapy versus prolonged‐course antibiotic therapy for HAP</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007577-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Discontinuation of antibiotics according to Clinical Pulmonary Infection Score</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 30‐day mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.10, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Episodes of superinfection or antimicrobial resistance <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.09, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Discontinuation of antibiotics according to Clinical Pulmonary Infection Score</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007577.pub3/references#CD007577-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007577.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD007577-note-0002">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD007577-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007577-note-0016">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007577-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD007577-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD007577-note-0006">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD007577-note-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD007577-note-0007">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD007577-note-0004">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD007577-note-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007577-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007577-note-0003">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007577\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007577\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007577\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007577\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007577\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=WcPhDegp&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007577.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007577.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007577.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007577.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007577.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726383625"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007577.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726383629"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007577.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9252aaaf9368',t:'MTc0MDcyNjM4My4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 